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ZUSAMMENFASSUNG 
Traditionell genutzte Pflanzen und Pflanzenprodukte finden vermehrt Eingang in den 
globalen Markt. Dies wirft Fragen auf im Bereich der Wirksamkeit und Toxikologie von 
Produkten, zu Qualitätsstandarts und zur Versorgung des Marktes mit den notwendigen 
Mengen an Pflanzenmaterial. Die vorliegende Dissertation widmet sich den Goji Beeren 
(Lycium spp.), die seit Jahrtausenden medizinisch und kulinarisch genutzt werden und heute 
global als gesundheitsfördernder Nahrungsmittelzusatz gehandelt werden.  
Das erste Kapitel widmet sich der Nutzungsgeschichte von Lycium weltweit, und mit einem 
Fokus auf Ostasien. Von weltweit insgesamt 97 Arten werden ca. 35 medizinisch und als 
Nahrung genutzt. Lycium barbarum L. und L. chinense Mill., beide aus Ostasien stammend, 
wurden globalisiert und L. barbarum wird in China im grossen Stil angebaut. Die 
Verwendung der beiden Arten kann in China mittels historischer Textquellen über die letzten 
2000 Jahre zurückverfolgt werden. Aktuelle medizinische Verwendungen mit historischem 
Hintergrund umfassen die Augengesundheit und die Nutzung als allgemeines Stärkungsmittel. 
Diese Anwendungen werden durch pharmakologische Studien gestützt. Aufgrund der 
historischen Dokumente ist eine vielfältigere Anwendung von Goji Produkten sowie die 
Verwendung zusätzlicher Arten denkbar. 
Im zweiten Kapitel werden Goji Proben aus klimatisch unterschiedlichen Anbauregionen 
Chinas aufgrund ihrer Inhaltsstoffe und Morphologie der Früchte miteinander verglichen. 
Ursprünglich wurde Goji im Osten des Landes in der Provinz Hebei angebaut, von wo aus 
sich der Anbau nach Westen in trockenere Gebiete hinein ausgedehnt hat. Heute gilt Ningxia 
in China als daodi Gebiet, d.h. als Region aus der die besten Goji Beeren kommen. Unsere 
Analysen stützen diese Aussage nicht. Metabolomische Unterschiede finden sich zwischen 
den Arten L. barbarum und L. chinense, nicht aber zwischen den Anbauregionen. L. chinense 
hat eine höhere antioxidative Aktivität als L. barbarum, und L. barbarum aus ariden 
Regionen zeigt den höchsten Zuckergehalt. Der metabolomische Ansatz kombiniert mit 
morphologischen Parametern ermöglicht es, verschiedene Typen von Goji zu charakterisieren, 
die sich für unterschiedliche medizinische und kulinarische Anwendungen anbieten.  
Im dritten Kapitel werden Wertschöpfungsketten von Goji analysiert, die sich bezüglich 
Produktequalität, Rückverfolgbarkeit und Verunreinigungen von Produkten unterscheiden. 
Dabei werden zehn verschiedene Formen von Ketten charakterisiert und diskutiert, und die 
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Wertschöpfung der verschiedenen Beteiligten vergleichend angeschaut. Obschon die Bauern 
einen grossen Beitrag zur Bearbeitung der Beeren leisten, sind sie im Allgemeinen nur 
marginal an der Wertschöpfung beteiligt. Es zeigt sich, dass die Wertschöpfung direkt mit der 
Produktequalität zusammenhängt. 
Horizontale Kooperation (z.B. Bauern-Kooperativen) und vertikale Integration zwischen 
Bauern und Verkäufern zeigen eine positive Auswirkung sowohl auf die Qualität der 
Produkte als auch auf die Wertschöpfung der Bauern. Wir erwarten, dass vollständig 
integrierte, vertikale Wertschöpfungsketten in Zukunft weite Verbreitung finden werden. 
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SYNOPSIS 
The popularity of plant-derived high value products as functional foods makes them 
an interesting research topic in the fields of ethnobotany, phytochemistry, food sciences and 
pharmacology. For a comprehensive understanding and meaningful use it is important to 
secure good product quality and to understand the phytochemistry and pharmacology of plant 
products, but also to relate current with traditional uses. Using an interdisciplinary approach 
this thesis investigates an Asian traditional herbal food and medicine known as goji (fruits of 
Lycium spp.). Goji has been recently advertised at a global level as “super food”. In this work 
culinary and medicinal uses of Lycium spp. in different cultures around the world have been 
reviewed and the use history in China over the last 2000 years has been analysed and 
correlated with general pharmacological activities; subsequently, a metabolomic and 
morphological comparative approach was used to analyze cultivated goji from different 
climatic regions. Finally, based on a detailed understanding of product quality and 
stakeholders’ behaviour, goji value chains were compared and a quality control strategy from 
a value chain perspective was developed. 
Chapter 1 comprises a systematic ethnobotanical investigation and description of the 
food and medicinal uses of Lycium L. over space and time. Relying on botanical, 
ethnobotanical and historical sources, it is found that 35 of totally 97 Lycium species have 
been used traditionally. Species and their usages differ among cultures; and, only L. 
barbarum L. and L. chinense Mill. from East Asia have been transformed into globally traded 
commodities. According to recent and historical Chinese herbals, their use can be traced back 
over the last two millennia. Recent applications with a historical record include improving 
eyesight as well as anti-aging and anti-fatigue. The pharmacological foundation of traditional 
and recent uses is mainly based on the following constituents / groups of compounds of the 
fruits: polysaccharides, zeaxanthin dipalmitate, vitamins, and betaine. Several national 
Pharmacopoeias adopt goji as a medicine, but quality criteria as well as the species they refer 
to differ among countries. We suggest that new food and medicinal products of lesser known 
Lycium spp. could be developed based on their traditional usages, and new uses of L. 
barbarum and L. chinense might be explored according to the historical records. 
Chapter 2 investigates the quality of commercial goji from different climatic regions 
of China. Our results do not justify superiority of a specific production area over other areas, 
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despite the fact that Ningxia is accepted as daodi region which means that it is acclaimed to 
produce the best goji. Many other regions are named as “home of goji”, indicating that they 
produce outstanding goji. Historically, goji was first cultivated in Hebei (monsoon climate) 
and from there transferred westwards into drier habitats. Goji from the monsoon, plateau and 
arid regions differ according to fruit morphology, but are not distinguishable from fruits of 
semi-arid cultivation regions. Metabolomic profiling separates the two species L. barbarum 
and L. chinense, but not the cultivation regions. L. chinense and samples from the semi-arid 
regions have significantly (p < 0.01) lower sugar contents and L. chinense shows the highest 
antioxidant activity. The metabolomic approach used combined with morphological analysis 
and bioactivity evaluation allows for capturing different goji quality clusters, and allows 
detecting different species. Therefore, we suggest using goji from different regions for 
different purposes, based on the specific morphological and chemical traits. 
Chapter 3 focuses on value chains of goji and quality control. Value chains of goji are 
mapped, while production behaviours and financial performances of stakeholders along the 
value chains are analysed. The traceability, reputation of products, and the probability of 
chemical contaminations of goji differ amongst value chains. Stakeholders’ revenue, 
behaviours, and quality of goji are correlated; horizontal collaborations and vertical 
integrations in value chains are beneficial to both quality and financial performance, while 
well-developed vertical integrated value chains are expected to become more important in the 
future. 
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GENERAL INTRODUCTION 
 
Ethnobotany: investigation of traditional plant knowledge  
We share our planet with over 374’000 plant species (Christenhusz and Byng, 2016). 
Plants are indispensable for humans: Besides their basic function of oxygen production, they 
produce food (directly or indirectly), offer building material for houses, yield fiber for clothes, 
and can be used as ornamentals, fuel, dye, and medicine. It is estimated that between 50’000 
and 80’000 flowering plant species are used for medicinal purposes worldwide (Chen et al., 
2016). In China alone, 11’146 plant species have been documented for their medicinal use, 
which is around one third of the total flora (Chen et al., 2010). Plant usage is shaped by 
culture and accessibility (e.g., Heinrich et al., 1998; Hsu and Harris, 2010; Weckerle et al., 
2006). As a result, people of different cultural backgrounds have been accumulating a wealth 
of knowledge on useful plants from their environments.  
Ethnobotany studies traditional plant knowledge and supports both, the understanding of 
cultural traditions and the conservation of biocultural diversity. It investigates the broad field 
of human plant interactions, and stretches into healthcare, drug discovery, or ritual culture 
(Flitsch, 1999; Heinrich, 2000; Heinrich et al., 2006; Hsu and Harris, 2010; Qureshi et al., 
2016; Staub et al., 2011a; Staub et al., 2011b; Weckerle et al., 2011; Yeung et al., 2018). For 
example, the discovery of artemisinin, an important anti-malaria compound, was inspired by 
the traditional use of Artemisia annua L. in Chinese Medicine (Tu, 2011; Tu, 2016). 
However, if traditional knowledge is misinterpreted it can become problematic: For example, 
the misuse of Aristolochia-related species, either due to adulteration or confusion of names, 
has caused renal failure in patients (Wu, 2007). Therefore, in-depth knowledge about 
traditional uses of plants is important for correct and safe use. 
 
Edible herbal medicine or functional food for good health 
Indigenous people often do not separate stringently between food and medicinal plants. 
Food as medicine and medicine as food is an integral part of all traditional medicinal systems 
for prevention of disease and promotion of health (Etkin and Ross, 1982). To stay healthy, 
wild collected food plants are traditionally used for soups, as boiled vegetables, in pies, 
salads, teas, jams, or as raw snack (Abbet et al., 2014; Guarrera and Savo, 2016; Leonti et al., 
2006; Sansanelli and Tassoni, 2014). Plants also have a long history as medicines and still 
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play an important role in biomedicine as well as alternative and complementary medicinal 
systems and traditional rural contexts (Chen et al., 2016; Dal Cero et al., 2014; Hamilton, 
2004). 
The usage of plants as medicine and food is continuous, and plants used for both 
medicine and food may be described as “edible herbal medicines” (Dal Cero, 2016; Etkin and 
Ross, 1982; Jennings et al., 2015; Kimondo et al., 2015; Quave and Pieroni, 2015; Rivera et 
al., 2005; Towns and Van Andel, 2016). Edible herbal medicines have nutritional properties 
like common foods, but at the same time can be used as therapeutics. Today, they are 
typically known as functional food or nutraceuticals and are part of the global market 
(Guarrera and Savo, 2016; Valussi and Scirè, 2012). In China, the State Food and Drug 
Administration announced that 88 herbal medicines registered in the Chinese pharmacopoeia 
are also permitted to be used as food; however, the integration of medicinal plants into daily 
diet is very common in China and many more species are used for this purpose; Medical diet 
as therapy or for prevention is an integral part of Chinese Medicine (Tan et al., 2017; Xu, 
2001). Health benefits of functional foods are related to bioactive compounds. For example, 
specific polysaccharides are known for their immunomodulatory effect, flavonoids exhibit 
antioxidative activity, caffeine stimulates the central nervous system, and phytosterols 
support heart health (Guarrera and Savo, 2016; Hilton, 2017; Xie et al., 2016). Since health is 
of major concern in our time, functional foods are increasingly in demand. The world market 
is estimated to 150 billion USD per year, with an annual growth of over 10% (Hilton, 2017). 
 
Quality control: assurance of safety and effectiveness 
Increasing trade and consumption of plant products comes along with a number of 
challenges, such as resource shortage or depletion, and quality variation of plant material 
(Booker et al., 2016b; Cassiday, 2017). The over-collection of wild plant resources can 
threaten species and cause ecological damage (Booker et al., 2016b; Wang et al., 2017; 
Winkler, 2011). It is estimated that worldwide up to 15’000 medicinal species are threatened 
and 20% of them are at the edge of extinction (Chen et al., 2016). Shortage may lead to 
substitution, adulteration or fake products (Booker et al., 2016b; Luo et al., 2018; Shi et al., 
2017). Cultivation can be a valuable option for medicinal plant production; but, the use of 
pesticides and herbicides may negatively influence product quality (Chen et al., 2016; Hoban 
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et al., 2017; Li et al., 2017; Wang et al., 2017; Yao et al., 2012). Therefore, quality of herbal 
medicine is of major concern, and quality control is critical for safe and efficacious use.  
Comprehensive quality inspection includes 1) reliable identification of plant material, 2) 
assurance of relevant bioactive compounds in the plant material, and 3) restriction and 
detection of harmful constituents (contaminants and impurities as well as endogenous toxic 
compounds) (Figure 1).  
Figure 1 The chemical constitution of a herbal medicine 
Species identification and exclusion of adulterants is the primary step of quality control. 
Beside morphological and anatomical methods, molecular identification, such as DNA 
barcoding, is frequently used or chemical methods are applied such as HPTLC fingerprinting 
(Booker et al., 2014; Chen et al., 2010; Raclariu et al., 2017; Xin et al., 2013). Useful 
bioactive compounds and their amount are detected by chromatographic approaches (Liang et 
al., 2004; Wagner et al., 2011). However, the relevant constituents for plant activity are not 
always known and the medicinal effect may be due to a number of compounds influencing 
each other. This is especially the case for Chinese Medicine where plant mixtures are 
preferentially administered (Donno et al., 2016). Harmful constituents need to be controlled 
strictly. Impurities such as dust, fungal or bacterial infections due to moisture are usually 
caused by improper processing conditions. Contaminants such as pesticide residues, heavy 
metals, and microbial toxins are frequently found in plant products; detection costs are 
relatively high and often not affordable for small producers. Harmful endogenous compounds 
such as aristolochic acid only occur in specific plant groups and need to be tested specifically 
(Ng et al., 2017). To ensure good quality it needs not only testing and control of plant 
products, but also regulations for production and processing (Booker and Heinrich, 2016). 
 
 
 
Herbal 
medicine 
Useful compounds 
Harmful constitutes 
Other compounds 
Endogenous toxics 
Contaminants  
Impurities  
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Value chain: stakeholders and products 
A botanical product always passes through numerous stages of production, such as 
cultivation, processing, and distribution, before it reaches the final consumers (Székács et al., 
2018). Therefore, the quality of plant products is impacted by many external factors, until 
they enter the global market. A number of regulatory frameworks are applied to control the 
procedures, such as the Hazard Analysis Critical Control Point (HACCP) of the FDA (USA), 
Good Agricultural Practice (GAP), and those of EMA/EFSA (EU); however, these 
regulations have their limitations and are not sufficient to guarantee good quality of plant 
products (Huang et al., 2017; Sperber, 2005; Will and Guenther, 2007; Yao et al., 2012).  
A value chain comprises all movements from the raw material to the final product across 
all parties involved, and can represent exhaustive flows of material, funds, and information 
(Datta, 2017; Lovis, 2008; Mentzer et al., 2001; Opara, 2003; Regattieri et al., 2007). Value 
chains affect both the quality of herbal products and the welfare of the stakeholders (Booker 
et al., 2012; Booker et al., 2016a; Heinrich, 2015). As a concept value chains connect the 
products with the stakeholders; and, with an interdisciplinary approach, they can be used as a 
tool to improve overall quality. This may include traceability of products, behaviour of 
stakeholders as well as revenue of stakeholders. 
 
Goji (fruits of Lycium spp.): from local to global 
In Asian countries goji, or wolfberry, has been used for at least 2000 years as a 
traditional food and medicine. Today, the global market advertises it as “super food”. The 
present thesis studies goji as a case study of a plant that was locally important for centuries 
before it became a global product. The thesis sheds light at its uses and trade over time from 
the above introduced perspectives:  
Traditional and recent knowledge of Lycium species is analysed from a botanical, 
ethnobotanical and historical perspective. Phytochemical and morphological approaches are 
used to characterize the quality of cultivated goji from different climatic regions in China, 
and, the different value chains involved in goji production were documented and are analysed 
for their potential to increase goji quality as well as fair sharing of revenues among 
stakeholders. 
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There is an old saying in Chinese Medicine: “good medicinal plant material results in 
good drugs” (药材好，药才好; yào cái hǎo, yào cái hǎo). Hopefully, this study contributes to 
our deepened scientific understanding of this very process.  
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A B S T R A C T
Ethnopharmacological relevance: Lycium is widely distributed in the arid to semi-arid environments of North and 
South America, Africa, and Eurasia. In recent years, Lycium barbarum and L. chinense have been advertised as 
“superfood” with healthy properties. Despite of its popularity, there is a lack of an integrated and critical ap-
praisal of the existing evidence for the use of Lycium.
Aim of the study: There is a need to understand: 1) Which species were used and how the uses of Lycium de-
veloped spatially and over time, 2) how uses diﬀer among regions with diﬀerent culture backgrounds, and 3) 
how traditional and current therapeutic and preventive health claims correlate with pharmacological ﬁndings. 
Methods: Information was retrieved from ﬂoras, taxonomic, botanical, and ethnobotanical databases, research 
articles, recent editions of historical Chinese herbals over the last 2000 years, and pharmacopoeias.
Results: Of totally 97 species, 35 have recorded uses as food and/or medicine worldwide. Usually the fruits are 
used. While 85% of the Lycium species occur in the Americas and Africa, 26% of them are used, but 9 out of 14 
species in Eurasia. In China, seven species and two varieties of the genus Lycium occur, of which four species have 
been used by diﬀerent ethnic groups. Only L. barbarum and L. chinense have been transformed into globally traded 
commodities. In China, based on the name “枸杞”, their use can be traced back over the last two mil-lennia. 
Lycium fruits for anti-aging, improving eyesight and nourishment were documented already in 500 C.E.(Mingyi 
Bielu). Recent ﬁndings explain the pharmacological foundations of the traditional uses. Especially 
polysaccharides, zeaxanthin dipalmitate, vitamins, betaine, and mixed extracts were reported to be responsible 
for anti-aging, improving eyesight, and anti-fatigue eﬀects.
Conclusions: The integration of historical, ethnobotanical, botanical, phytochemical and pharmacological data has 
enabled a detailed understanding of Lycium and its wider potential. It highlights that the focus so far has only been 
on two species and that the genus can potentially yield a wide range of other products with diﬀerent properties.
1. Introduction
Plant-based products are important sources of both food and med-
icine. Whether a plant is used as food or medicine depends on a wide
range of factors, but is not necessarily intrinsic to its pharmacological or
nutritional properties (Leonti, 2011; Jennings et al., 2015). In the last
decades the variety of consumed crops has increased globally, espe-
cially of local agricultural varieties and species collected from the wild.
These are becoming more important for human nutrition and for
medicinal uses (Heywood, 2011). This increase is often based on tra-
ditional knowledge, which is deﬁned as knowledge innovations and
practices of indigenous and local communities embodying traditional
lifestyles relevant for the conservation and sustainable use of biological
diversity (Xue, 2011). Traditional knowledge on plants can be used as a
starting point to develop new medicines, e.g., the discovery of artemi-
sinin (Tu, 2015), while it should be protected subject to the Nagoya
Protocol (Ngo et al., 2013; Buch and Hamilton, 2011). Therefore, tra-
ditional knowledge on plants continues to play an important role in
human lives for both food and medical purposes.
The fruit, leaf, root bark, and young shoot of many species of the
genus Lycium L. have long been used as local foods and/or medicines.
Recently, Lycium fruits, known as goji or wolfberry, have become in-
creasingly popular in the western world because of their nutritional
properties (Qian et al., 2017; Amagase, 2010; Potterat, 2010; Amagase
and Farnsworth, 2011); they are even advertised as “superfood” in
Europe and North America (Wolfe, 2010; Chang and So, 2015).
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Phytochemical studies indicate that the richness in numerous constitu-
tions of diﬀerent classes, such as polysaccharides, carotenoids, ﬂavo-
noids, alkaloids, amides, terpenoids, and so on, endows Lycium species
with a variety of biological activities (Qian et al., 2017; Yao et al., 2011).
Also, pharmacopoeias adopted the most popular species, L. barbarum
and/or L. chinense, as herbal medicines (Wagner et al., 2011).
Thus, species of the genus Lycium serve as widely used source of food
and medicine. Despite of its popularity, there is a lack of an integrated and
critical appraisal of the existing evidence for the use of Lycium. From a
botanical and ethnopharmacological perspective, there is a need to un-
derstand: 1) Which species were used and how the uses of Lycium devel-
oped spatially and over time, 2) how uses diﬀer among regions with dif-
ferent culture backgrounds, and 3) how traditional and current therapeutic
and preventive health claims correlate with pharmacological ﬁndings.
To answer these questions we started with a botanical overview of
the genus and its accepted species, and did a comprehensive study and
analysis of a large body of literature and databases.
2. Methods
Overall, information was obtained from ﬂoras, taxonomic, botanical,
and ethnobotanical databases, research articles, recent editions of his-
torical Chinese herbals, and pharmacopoeias. All sources used to extract
information as well as the applied keywords are given in Table 1.
For species names and synonyms we relied on The Plant List (2013)
and local ﬂoras. Distribution data and biogeographic information were
obtained from IPNI (2015), GBIF (2017), LycieaeWeb (2017) and re-
search articles. Morphological characters were extracted from the re-
gional ﬂoras and type specimens in the Chinese National Herbarium
(PE) were consulted for veriﬁcation.
To gather information about the use of Lycium species at a global
level, the following strategy was used: 1) “Lycium” was used as key
word to search within the ethnobotanical databases (Table 1). 2) In
google scholar, “Lycium” and “traditional” or “ethnobotany” or “med-
icine” or “food” or “herb” were searched. 3) The validated species
names were searched within the ethnobotanical databases and google
scholar. And 4) the words “ethnobotanical survey” were searched, then
“Lycium” was searched in the texts. 5) “Lycium” was also searched in
regional ethnobotanical and herbal medicine monographs. Results were
integrated with species data.
For the history of Lycium's use we focused on China, both because a
continuous documentation over the last two millennia is available, and
the current boom of goji use originated in China. We relied on modern
translations of classical Chinese herbals. At least one herbal per dynasty
was included. If several contemporary herbals existed, the most com-
prehensive one and herbals adding new information were used. In total,
32 herbals from ca. C.E. 100–2006 were considered.
In order to ﬁnd scientiﬁc evidence for traditional uses, we did a
literature search on the phytochemistry and pharmacology of Lycium
species. The main bioactivities and the related compounds or extracts
were listed in one table.
To compare Lycium records in pharmacopoeias of diﬀerent regions,
“Lycium” was searched in the pharmacopoeias listed in the Index of the
World Pharmacopoeias and Pharmacopoeial Authorities (document
QAS/11.453/ Rev.6) published by WHO in 2016. Lycium was only
found in the pharmacopoeias of seven Asian countries and regions.
In order to study the change of the records over time, all editions
(from 1953 to 2015) of the Chinese pharmacopoeia were consulted.
Additionally, all the parameters for Lycium fruit and Lycium root
included in the pharmacopoeias were extracted and analyzed with a
cluster analysis to understand the relationships among pharmacopoeias.
R and the package “ape” was employed (R Core Team, 2017; Paradis
et al., 2004) for cluster analysis.
3. Results
3.1. Botany
The genus Lycium (Solanaceae) widely grows in arid to semi-arid en-
vironments of the temperate zones (Fukuda, 2001; Miller et al., 2011;
Table 1
Data sources used.
Themes Data sources Key words
Taxonomy & Systematics The Plant List (2013), http://www.theplantlist.org/; GBIF (Global Biodiversity Information
Facility), 2017, https://demo.gbif.org/; IPNI (The International Plant Names Index), 2015, http://
www.ipni.org/; LycieaeWeb (2017), http://jsmiller.people.amherst.edu/LycieaeWeb/Project_
Lycieae.html; African Plant Database (version 3.4.0), 2017. http://www.ville-ge.ch/musinfo/bd/
cjb/africa/; EuroPlusMed PlantBase (2011), http://ww2.bgbm.org/; eFloras (2017). http://www.
eﬂoras.org; Flora of China (Vol. 17), 1994. http://foc.eﬂora.cn/; Flora of China (Vol. 67), 1994;
Flora of Victoria, 2015, https://vicﬂora.rbg.vic.gov.au/; Neotropical Flora (2017), http://
hasbrouck.asu.edu/neotrop/plantae/index.php; Flora of Israel (2017), http://ﬂora.org.il/plants/;
Flora of Pakistan, 1980; Flora of the great plains, 1986; Flora of North America (2009), http://
luirig.altervista.org/ﬂora/taxa/north-america.php; NPGS (National Plant Germplasm System),
2016. https://npgsweb.ars-grin.gov/; Flora of Argentina (1992). http://www.ﬂoraargentina.edu.
ar/; and scientiﬁc articles of Google scholar, science direct, web of science, NCBI (National Center
for Biotechnology Information), and NEBIS (Network of Libraries and Information Centers in
Switzerland).
Lycium, and the speciﬁc species names.
Traditional uses globally Dr. Duke's Phytochemical and Ethnobotanical Databases, 1992–2016, http://phytochem.nal.usda.
gov/; NPGS (National Plant Germplasm System), 2016. https://npgsweb.ars-grin.gov/; FEIS (Fire
Eﬀects Information System), 2016, http://www.feis-crs.org/feis/; NAEB (Native American
Ethnobotany Database), 2003. http://naeb.brit.org/; PFAF (Plants for a Future), 2016, http://
www.pfaf.org/; ETHMEDmmm (The Data Base of Ethno-medicines in the world), 2016, http://
ethmed.u-toyama.ac.jp; Medicinal Plant Names Services (2017) (http://mpns.kew.org); and
scientiﬁc articles of Google scholar, science direct, web of science, NCBI (National Center for
Biotechnology Information), and NEBIS (Network of Libraries and Information Centers in
Switzerland).
Lycium, the speciﬁc species names,
Traditional use, food, medicine,
ethnobotanical survey.
Use history in Chinese medicine Chinese herbals and agronomy monographs (from ca. C.E. 100–2006; see S1); regional books of
ethnobotany and herbal medicine in China. (Search with” nationality + 医药” in google book
(https://books.google.com/).
“杞”,“地骨皮”
Pharmacopoeias Chinese Pharmacopoeia (2015, vol. 1), European Pharmacopoeia (9.0), Japanese Pharmacopoeia
(16th), Korean Pharmacopoeia (9th), Taiwan TCM Pharmacopoeia (2013), Vietnam
Pharmacopoeia (4th), Ayurveda API (Vol. 6); all editions of Chinese Pharmacopoeia (1953–2015)
British Pharmacopoeia Commision (2017).
Lycium
R. Yao et al. Journal of Ethnopharmacology 212 (2018) 50–66
22
Ta
bl
e
2
Th
e
di
st
ri
bu
ti
on
of
Ly
ci
um
sp
ec
ie
s
an
d
th
ei
r
us
es
as
fo
od
an
d
m
ed
ic
in
e.
Sp
ec
ie
s
na
m
e
D
is
tr
ib
ut
io
n
Fo
od
us
e
M
ed
ic
in
e
us
e
R
ef
er
en
ce
sa
fo
r
pl
an
t
us
es
L.
ac
ut
ifo
liu
m
E.
M
ey
.
ex
D
un
al
So
ut
h
A
fr
ic
a,
M
ad
ag
as
ca
r,
Le
so
th
o
St
ar
ch
of
ro
ot
re
co
m
m
en
de
d
as
fa
m
in
e
fo
od
fo
r
ex
te
nd
in
g
br
ea
d
ﬂ
ou
r;
ba
rk
as
co
nd
im
en
t.
Po
un
de
d
ba
rk
to
ke
ep
a
pe
rs
on
in
go
od
he
al
th
U
SD
A
(1
99
2–
20
16
);
D
ha
r
et
al
.(
20
11
);
W
at
t
an
d
W
ar
m
el
o
(1
93
0)
;L
ev
an
d
A
m
ar
(2
00
6)
;M
PN
S,
20
17
L.
af
ru
m
L.
So
ut
h
A
fr
ic
a,
Fr
an
ce
,T
un
is
ia
,S
w
ed
en
,G
er
m
an
y,
N
et
he
rl
an
ds
,
m
ed
ie
va
l
C
ai
ro
Fr
ui
t:
fo
od
Le
av
es
,f
ru
it
s,
ro
ot
s
fo
r
ey
e
di
se
as
es
,c
ou
gh
U
SD
A
,1
99
2–
20
16
;P
FA
F
(2
01
6)
;M
id
dl
ed
it
ch
(2
01
2)
;L
ev
an
d
A
m
ar
(2
00
6)
;M
PN
S,
20
17
L.
am
eg
hi
no
iS
pe
g.
A
rg
en
ti
na
N
M
(n
ot
m
en
ti
on
ed
)
N
M
–
L.
am
er
ic
an
um
Ja
cq
.
Ba
ha
m
as
;
C
ub
a;
H
ai
ti
;D
om
in
ic
an
R
ep
ub
lic
;I
sl
as
de
Ba
rl
ov
en
to
;
V
en
ez
ue
la
;
C
ol
om
bi
a;
C
os
ta
R
ic
a;
Ec
ua
do
r;
Pe
ru
;B
ol
iv
ia
;
Pa
ra
gu
ay
;A
rg
en
ti
na
fr
ui
t
as
fo
od
N
M
A
re
na
s
an
d
Sc
ar
pa
(2
00
7)
L.
am
oe
nu
m
D
am
m
er
So
ut
h
A
fr
ic
a,
N
am
ib
ia
N
M
N
M
–
L.
an
at
ol
ic
um
A
.B
ay
to
p
&
R
.R
.M
ill
Tu
rk
ey
,A
rm
en
ia
N
M
N
M
–
L.
an
de
rs
on
ii
A
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
N
M
N
A
EB
(2
00
3)
;P
FA
F
(2
01
6)
;S
au
nd
er
s
(1
92
0)
;C
ro
ss
w
hi
te
(1
98
1)
;H
od
gs
on
(2
00
1)
;N
ew
to
n
(2
01
3)
L.
an
de
rs
on
ii
va
r.
de
se
rt
ic
ol
a
(C
.L
.
H
it
ch
c.
)
Je
ps
.
U
S,
M
ex
ic
o
N
M
N
M
–
L.
ar
en
ic
ol
um
M
ie
rs
So
ut
h
A
fr
ic
a,
Le
so
th
o,
Bo
ts
w
an
a,
U
ni
te
d
St
at
es
N
M
N
M
–
L.
at
hi
um
Be
rn
ar
de
llo
A
rg
en
ti
na
N
M
N
M
–
L.
au
st
ra
le
F.
M
ue
ll.
A
us
tr
al
ia
Fr
ui
t
as
fo
od
N
M
PF
A
F
(2
01
6)
;J
ea
ne
s
(1
99
9)
;C
la
rk
e
(1
99
8)
L.
ba
rb
ar
um
L.
W
id
el
y
di
st
ri
bu
te
d
in
A
si
a,
Eu
ro
pe
,N
or
th
A
m
er
ic
a,
an
d
A
us
tr
ia
;a
ls
o
ap
pe
ar
s
in
A
fr
ic
a
an
d
So
ut
h
A
m
er
ic
a
Fr
ui
t,
sh
oo
t,
le
af
as
fo
od
Fr
ui
t,
ro
ot
,l
ea
f,
ca
ly
x,
ba
rk
,a
nd
w
ho
le
pl
an
t
as
m
ed
ic
in
es
fo
r
a
va
ri
et
y
of
di
se
as
es
U
SD
A
,1
99
2–
20
16
;P
FA
F
(2
01
6)
;L
im
(2
01
2)
;L
iu
et
al
.(
20
04
);
Li
et
al
.(
20
01
);
A
li
(1
96
4)
;E
TH
M
ED
m
m
,2
01
6;
K
ol
ev
a
et
al
.
(2
01
5)
;D
uk
e
(2
00
2)
;D
ee
b
et
al
.(
20
13
);
M
PN
S,
20
17
;
Q
ua
tt
ro
cc
hi
(2
01
2)
L.
be
rb
er
io
id
es
C
or
re
ll
U
S
N
M
N
M
–
L.
be
rl
an
di
er
iD
un
al
U
S,
M
ex
ic
o,
G
er
m
an
y
Fr
ui
t
as
fo
od
Pl
an
t
as
m
ed
ic
in
e
FE
IS
(2
01
6)
;P
FA
F
(2
01
6)
;K
ea
rn
ey
et
al
.(
19
60
);
Po
w
el
l,
19
88
;
N
ew
to
n
(2
01
3)
L.
be
rl
an
di
er
iv
ar
.p
ar
vi
ﬂ
or
um
(A
.G
ra
y)
A
.T
er
ra
cc
.
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
Pl
an
t
as
m
ed
ic
in
e
H
od
gs
on
(2
00
1)
L.
bo
sc
iif
ol
iu
m
Sc
hi
nz
N
am
ib
ia
,S
ou
th
A
fr
ic
a,
Bo
ts
w
an
a,
A
ng
ol
a,
Zi
m
ba
bw
e
Le
af
as
fo
od
N
M
N
di
th
ia
an
d
Pe
rr
in
,2
00
6
L.
br
ev
ip
es
Be
nt
h.
U
S,
M
ex
ic
o
N
M
N
M
–
L.
ca
lif
or
ni
cu
m
A
.G
ra
y
U
S,
M
ex
ic
o,
Ja
m
ai
ca
N
M
N
M
–
L.
ca
ri
na
tu
m
S.
W
at
so
n
M
ex
ic
o,
Ja
m
ai
ca
N
M
N
M
–
L.
ca
ro
lin
ia
nu
m
W
al
te
r
U
S,
M
ex
ic
o,
C
ub
a,
Ea
st
er
Is
la
nd
,
W
es
t
In
di
es
fr
ui
t
as
fo
od
N
M
PF
A
F
(2
01
6)
L.
ca
ro
lin
ia
nu
m
va
r.
qu
ad
ri
ﬁ
du
m
(M
oc
.&
Se
ss
é
ex
D
un
al
)
C
.L
.
H
it
ch
c.
N
M
N
M
–
L.
ce
st
ro
id
es
Sc
hl
td
l.
A
rg
en
ti
na
,B
ol
iv
ia
,
U
ru
gu
ay
,B
ra
zi
l,
A
us
tr
al
ia
,
G
er
m
an
y,
U
K
N
M
A
na
lg
es
ic
R
on
di
na
et
al
.(
20
08
);
M
PN
S,
20
17
L.
ch
an
ar
Ph
il.
A
rg
en
ti
na
,B
ol
iv
ia
,
C
hi
le
N
M
N
M
–
L.
ch
ile
ns
e
Be
rt
er
o
A
rg
en
ti
na
,C
hi
le
,P
ar
ag
ua
y,
Bo
liv
ia
,
U
K
,B
ra
zi
l,
Sw
it
ze
rl
an
d,
Ec
ua
do
r,
Fr
an
ce
N
M
Fr
ui
t
as
m
ed
ic
in
e
N
PG
S
(2
01
6)
;U
SD
A
,1
99
2–
20
16
L.
ch
in
en
se
M
ill
.
W
id
el
y
di
st
ri
bu
te
d
in
A
si
a,
Eu
ro
pe
,N
or
th
A
m
er
ic
a,
an
d
A
us
tr
ia
Fr
ui
t,
le
af
an
d
yo
un
g
sh
oo
t
as
fo
od
;
se
ed
fo
r
co
ﬀ
ee
;l
ea
f
as
te
a
Fr
ui
t,
ro
ot
,l
ea
f,
ba
rk
,a
nd
w
ho
le
pl
an
t
as
m
ed
ic
in
es
N
PG
S
(2
01
6)
;P
FA
F
(2
01
6)
;U
SD
A
,1
99
2–
20
16
;L
im
(2
01
2)
;
ET
H
M
ED
m
m
,2
01
6;
M
PN
S,
20
17
;D
uk
e
(2
00
2)
;Q
ua
tt
ro
cc
hi
(2
01
2)
L.
ch
in
en
se
va
r.
po
ta
ni
ni
i(
Po
ja
rk
.)
A
.M
.L
u
C
hi
na
N
M
R
oo
t
ba
rk
as
m
ed
ic
in
e
Li
et
al
.(
20
01
)
L.
ci
lia
tu
m
Sc
hl
td
l.
A
rg
en
ti
na
,B
ra
zi
l,
Bo
liv
ia
N
M
Le
af
as
m
ed
ic
in
e
fo
r
di
ge
st
iv
e
an
d
st
om
ac
h
in
ﬂ
am
m
at
io
ns
Tr
ill
o
et
al
.(
20
10
);
To
le
do
et
al
.(
20
14
)
L.
ci
ne
re
um
Th
un
b.
So
ut
h
A
fr
ic
a,
Bo
ts
w
an
a,
N
am
ib
ia
,L
es
ot
ho
Fr
ui
t
as
fo
od
Tr
ea
t
he
ad
ac
he
an
d
rh
eu
m
at
is
m
;
ro
ot
:a
no
dy
ne
,k
id
ne
y
di
se
as
e,
pe
rf
um
e
Iw
u
(2
01
4)
;D
ha
r
et
al
.(
20
11
);
V
an
D
am
m
e
(1
99
8)
;M
PN
S,
20
17
L.
co
op
er
iA
.G
ra
y
M
ex
ic
o,
U
S
N
M
N
M
–
L.
cu
ne
at
um
D
am
m
er
A
rg
en
ti
na
,P
ar
ag
ua
y,
Bo
liv
ia
N
M
N
M
–
L.
cy
at
hi
fo
rm
um
C
.L
.H
it
ch
c.
Bo
liv
ia
,
A
rg
en
ti
na
N
M
N
M
–
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
R. Yao et al. Journal of Ethnopharmacology 212 (2018) 50–66
23
Ta
bl
e
2
(c
on
tin
ue
d)
Sp
ec
ie
s
na
m
e
D
is
tr
ib
ut
io
n
Fo
od
us
e
M
ed
ic
in
e
us
e
R
ef
er
en
ce
sa
fo
r
pl
an
t
us
es
L.
cy
lin
dr
ic
um
K
ua
ng
&
A
.M
.L
u
C
hi
na
N
M
N
M
–
L.
da
sy
st
em
um
Po
ja
rk
.
C
hi
na
,
Ir
an
Fr
ui
t
as
fo
od
Fr
ui
t
as
m
ed
ic
in
e
A
li
(1
98
0)
;A
za
di
et
al
.(
20
07
);
Li
et
al
.(
20
01
);
L.
de
cu
m
be
ns
W
el
w
.e
x
H
ie
rn
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,A
ng
ol
a
N
M
N
M
–
L.
de
ns
ifo
liu
m
W
ig
gi
ns
M
ex
ic
o
N
M
N
M
L.
de
pr
es
su
m
St
oc
ks
Ir
an
,R
us
si
a,
Is
ra
el
,T
ur
km
en
is
ta
n,
Ir
aq
,P
al
es
ti
ni
an
Te
rr
it
or
y,
A
fg
ha
ni
st
an
,T
ur
ke
y,
Pa
ki
st
an
,J
or
da
n
N
M
Le
af
an
d
fr
ui
t
fo
r
ki
dn
ey
pr
ob
le
m
s
Ta
ba
ra
ki
et
al
.(
20
13
);
G
ha
se
m
i
et
al
.(
20
13
)
L.
de
se
rt
iP
hi
l.
C
hi
le
N
M
N
M
–
L.
di
sp
er
m
um
W
ig
gi
ns
M
ex
ic
o
N
M
N
M
–
L.
di
st
ic
hu
m
M
ey
en
Pe
ru
,
Bo
liv
ia
,C
hi
le
N
M
N
M
–
L.
di
va
ri
ca
tu
m
R
us
by
Pe
ru
,
Bo
liv
ia
N
M
N
M
–
L.
ed
ge
w
or
th
ii
M
ie
rs
In
di
a,
Pa
ki
st
an
,I
ra
n
N
M
N
M
–
L.
ee
ni
iS
.M
oo
re
N
am
ib
ia
N
M
N
M
–
L.
el
on
ga
tu
m
M
ie
rs
A
rg
en
ti
na
N
M
Le
af
fo
r
di
ge
st
iv
e
To
le
do
et
al
.,
20
14
;T
ri
llo
et
al
.,
20
10
.
L.
eu
ro
pa
eu
m
L.
Sp
ai
n,
Fr
an
ce
,I
sr
ae
l,
Pa
le
st
in
ia
n
Te
rr
it
or
y,
A
lg
er
ia
,
Po
rt
ug
al
,I
nd
ia
,T
un
is
ia
,E
gy
pt
Fr
ui
t
an
d
yo
un
g
sh
oo
t
as
fo
od
Fr
ui
t,
le
af
,
ba
rk
,a
nd
w
ho
le
pl
an
t
ar
e
us
ed
fo
r
a
va
ri
et
y
of
tr
ea
tm
en
ts
PF
A
F
(2
01
6)
;F
ra
tk
in
(1
99
6)
;D
af
ni
an
d
Y
an
iv
(1
99
4)
;S
ai
d
et
al
.
(2
00
2)
;E
l
H
am
ro
un
i,
20
01
;B
ou
lla
rd
(2
00
1)
;P
ie
ro
ni
et
al
.
(2
00
2)
;A
l-Q
ur
an
(2
00
7)
;E
l-M
ok
as
ab
i
(2
01
4)
;T
ur
ke
r
et
al
.
(2
01
2)
;L
ep
or
at
ti
an
d
G
he
di
ra
(2
00
9)
;L
ic
at
a
et
al
.(
20
16
);
M
PN
S,
20
17
L.
ex
se
rt
um
A
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
N
M
N
A
EB
(2
00
3)
;H
od
gs
on
(2
00
1)
;N
ew
to
n
(2
01
3)
;N
ab
ha
n
et
al
.
(1
98
2)
L.
fe
ro
ci
ss
im
um
M
ie
rs
A
us
tr
al
ia
,
So
ut
h
A
fr
ic
a,
N
ew
Ze
al
an
d,
M
or
oc
co
,
N
am
ib
ia
,U
S,
Le
so
th
o,
Sp
ai
n,
N
or
fo
lk
Is
la
nd
,
Tu
ni
si
a
Fr
ui
t
as
fo
od
Pl
an
t
fo
r
de
to
xi
ca
ti
on
of
na
rc
ot
ic
po
is
on
in
g
W
at
t
an
d
Br
ey
er
-B
ra
nd
w
ijk
(1
96
2)
;A
rn
ol
d
et
al
.(
20
02
);
M
PN
S,
20
17
L.
fr
em
on
tii
A
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
N
M
N
A
EB
(2
00
3)
;P
FA
F
(2
01
6)
;W
at
ta
nd
Br
ey
er
-B
ra
nd
w
ijk
(1
96
2)
;
M
PN
S,
20
17
L.
fu
sc
um
M
ie
rs
A
rg
en
ti
na
N
M
N
M
–
L.
ga
ri
ep
en
se
A
.M
.V
en
te
r
So
ut
h
A
fr
ic
a,
N
am
ib
ia
N
M
N
M
–
L.
gi
lli
es
ia
nu
m
M
ie
rs
A
rg
en
ti
na
,C
hi
le
N
M
N
M
–
L.
gl
om
er
at
um
Se
nd
tn
.
A
rg
en
ti
na
,P
ar
ag
ua
y,
Bo
liv
ia
,B
ra
zi
l,
C
hi
na
N
M
N
M
–
L.
gr
an
di
ca
ly
x
Jo
ub
er
t&
V
en
te
r
So
ut
h
A
fr
ic
a,
N
am
ib
ia
N
M
N
M
–
L.
ha
nt
am
en
se
A
.M
.V
en
te
r
So
ut
h
A
fr
ic
a
N
M
N
M
–
L.
ha
ss
ei
G
re
en
e
U
S
N
M
N
M
–
L.
hi
rs
ut
um
D
un
al
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,B
ot
sw
an
a
N
M
N
M
–
L.
ho
rr
id
um
Th
un
b.
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,M
ad
ag
as
ca
r,
Bo
ts
w
an
a,
Le
so
th
o,
A
ng
ol
a,
Ir
an
,M
au
ri
ti
us
,
Tu
rk
ey
N
M
N
M
–
L.
hu
m
ile
Ph
il.
C
hi
le
,A
rg
en
ti
na
N
M
N
M
–
L.
in
fa
us
tu
m
M
ie
rs
A
rg
en
ti
na
,C
ol
om
bi
a,
Bo
liv
ia
,E
cu
ad
or
,D
om
in
ic
an
,
Tu
rk
s
A
nd
C
ai
co
s
Is
la
nd
s,
Ja
m
ai
ca
,P
er
u,
Po
rt
ug
al
,
Pa
ra
gu
ay
N
M
N
M
–
L.
in
tr
ic
at
um
Bo
is
s.
Sp
ai
n,
M
or
oc
co
,
Po
rt
ug
al
,M
au
ri
ta
ni
a,
A
lg
er
ia
,
Eg
yp
t,
Sa
ud
i
A
ra
bi
a,
Tu
ni
si
a,
Tu
ni
si
a,
It
al
y
N
M
Se
ed
:h
el
m
in
th
ia
si
s,
di
ge
st
iv
e;
fr
ui
t:
ey
e
di
se
as
es
A
bo
ur
i
et
al
.(
20
12
);
O
uh
ad
do
u,
.
et
al
.(
20
14
);
Bo
ul
ila
an
d
Be
ja
ou
i
(2
01
5)
;A
bd
en
na
ce
r
et
al
.(
20
15
);
M
PN
S,
20
17
L.
is
th
m
en
se
F.
C
hi
an
g
M
ex
ic
o
N
M
N
M
–
L.
le
io
st
em
um
W
ed
d.
C
hi
le
,P
er
u,
M
ex
ic
o
N
M
N
M
–
L.
m
ac
ro
do
n
A
.G
ra
y
U
S,
M
ex
ic
o
N
M
N
M
–
L.
m
ak
ra
ni
cu
m
Sc
ho
ne
be
ck
-T
em
es
y
Pa
ki
st
an
N
M
N
M
–
L.
m
ar
tii
Se
nd
tn
.
Br
az
il,
C
ub
a
N
M
N
M
–
L.
m
as
ca
re
ne
ns
e
A
.M
.V
en
te
r&
A
.J
.S
co
tt
M
au
ri
ti
us
,M
ad
ag
as
ca
r,
So
ut
h
A
fr
ic
a,
M
oz
am
bi
qu
e,
R
eu
ni
on
N
M
N
M
–
L.
m
eg
ac
ar
pu
m
W
ig
gi
ns
M
ex
ic
o
N
M
N
M
–
L.
m
in
im
um
C
.L
.H
it
ch
c.
Ec
ua
do
r
N
M
N
M
–
L.
m
in
ut
ifo
liu
m
R
em
y
C
hi
le
,A
rg
en
ti
na
,M
au
ri
ti
us
N
M
N
M
–
L.
m
or
on
gi
iB
ri
tt
on
A
rg
en
ti
na
,P
ar
ag
ua
y,
Bo
liv
ia
N
M
N
M
–
L.
no
do
su
m
M
ie
rs
A
rg
en
ti
na
,M
ex
ic
o,
Pa
ra
gu
ay
,E
cu
ad
or
,V
en
ez
ue
la
,
Bo
liv
ia
,
Pe
ru
N
M
N
M
–
L.
ox
yc
ar
pu
m
D
un
al
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,A
ng
ol
a,
U
S
N
M
U
se
d
as
m
ed
ic
in
e,
no
de
ta
ils
A
rn
ol
d
et
al
.(
20
02
);
M
PN
S,
20
17
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
R. Yao et al. Journal of Ethnopharmacology 212 (2018) 50–66
24
Ta
bl
e
2
(c
on
tin
ue
d)
Sp
ec
ie
s
na
m
e
D
is
tr
ib
ut
io
n
Fo
od
us
e
M
ed
ic
in
e
us
e
R
ef
er
en
ce
sa
fo
r
pl
an
t
us
es
L.
pa
lli
du
m
M
ie
rs
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
Pl
an
t
an
d
ro
ot
as
m
ed
ic
in
e,
fo
r
to
ot
ha
ch
e
an
d
ch
ic
ke
np
ox
N
A
EB
(2
00
3)
;F
EI
S
(2
01
6)
;P
FA
F
(2
01
6)
;K
in
ds
ch
er
et
al
.
(2
01
2)
;S
au
nd
er
s
(1
92
0)
;M
cC
le
nd
on
(1
92
1)
;P
ow
el
l
(1
98
8)
;
V
in
es
(1
96
0)
;H
od
gs
on
(2
00
1)
;M
id
dl
ed
it
ch
(2
01
2)
;M
PN
S,
20
17
;Q
ua
tt
ro
cc
hi
(2
01
2)
L.
pa
ri
sh
ii
A
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
N
M
N
ab
ha
n
et
al
.(
19
82
);
H
od
gs
on
(2
00
1)
L.
pa
ri
sh
ii
va
r.
m
od
es
tu
m
(I
.M
.J
oh
ns
t.)
F.
C
hi
an
g
M
ex
ic
o
N
M
N
M
–
L.
pe
tr
ae
um
Fe
in
br
un
It
al
y,
Jo
rd
an
;E
ur
oP
lu
sM
ed
Pl
an
tB
as
e
N
M
N
M
–
L.
pi
lif
ol
iu
m
C
.H
.W
ri
gh
t
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,B
ot
sw
an
a
N
M
N
M
–
L.
pr
un
us
-s
pi
no
sa
D
un
al
So
ut
h
A
fr
ic
a,
N
am
ib
ia
N
M
U
se
d
as
m
ed
ic
in
e,
no
de
ta
ils
A
rn
ol
d
et
al
.(
20
02
);
M
PN
S,
20
17
L.
pu
be
ru
lu
m
A
.G
ra
y
U
S,
M
ex
ic
o
N
M
N
M
–
L.
pu
bi
tu
bu
m
C
.L
.H
it
ch
c.
U
S,
M
ex
ic
o
N
M
N
M
–
L.
pu
m
ilu
m
D
am
m
er
So
ut
h
A
fr
ic
a,
N
am
ib
ia
N
M
N
M
–
L.
ra
ch
id
oc
la
du
m
D
un
al
C
hi
le
N
M
N
M
–
L.
re
pe
ns
Sp
eg
.
A
rg
en
ti
na
,U
S
N
M
N
M
–
L.
ri
ch
ii
A
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
N
M
W
at
so
n
(1
88
8)
;H
od
gs
on
(2
00
1)
L.
ru
th
en
ic
um
M
ur
ra
y
C
hi
na
,
Ir
an
,A
fg
ha
ni
st
an
,I
nd
ia
,M
ex
ic
o,
Pa
ki
st
an
,
R
us
si
an
,
Tu
rk
m
en
is
ta
n,
G
eo
rg
ia
Fr
ui
t
as
fo
od
Fr
ui
t:
op
ht
ha
lm
ic
,b
lin
dn
es
s
(v
et
er
in
ar
y)
;l
ea
f:
re
m
ov
e
bl
oc
ke
d
ur
in
e;
di
ur
et
ic
U
SD
A
(,
19
92
–,
20
16
);
PF
A
F
(2
01
6)
;B
al
la
bh
et
al
.(
20
08
);
G
ai
ro
la
et
al
.(
20
14
);
M
PN
S,
20
17
L.
sa
nd
w
ic
en
se
A
.G
ra
y
Is
la
nd
s
ac
ro
ss
th
e
Pa
ci
ﬁ
c
(E
as
te
r
Is
la
nd
,H
aw
ai
ia
n
Is
la
nd
s,
O
ga
sa
w
ar
a
Is
la
nd
s
an
d
D
ai
to
u
Is
la
nd
)
Fr
ui
t
as
fo
od
N
M
PF
A
F
(2
01
6)
;M
id
dl
ed
it
ch
(2
01
2)
L.
sc
hi
zo
ca
ly
x
C
.H
.W
ri
gh
t
So
ut
h
A
fr
ic
a,
Bo
ts
w
an
a,
N
am
ib
ia
,M
oz
am
bi
qu
e
N
M
N
M
–
L.
sc
hr
ei
te
ri
F.
A
.B
ar
kl
ey
A
rg
en
ti
na
N
M
N
M
–
L.
sc
hw
ei
nf
ur
th
ii
D
am
m
er
Sp
ai
n,
Is
ra
el
,M
or
oc
co
,
G
re
ec
e,
Po
rt
ug
al
,A
lg
er
ia
,
Eg
yp
t,
Tu
ni
si
a,
M
au
ri
ta
ni
a,
C
yp
ru
s
N
M
Le
af
an
d
fr
ui
t
ar
e
us
ed
fo
r
st
om
ac
h
ul
ce
r
PF
A
F
(2
01
6)
;A
ud
a
(2
01
1)
;J
am
ou
s
et
al
.(
20
15
)
L.
sh
aw
ii
R
oe
m
.&
Sc
hu
lt
.
Is
ra
el
,P
al
es
ti
ni
an
Te
rr
it
or
y,
Sa
ud
i
A
ra
bi
a,
Et
hi
op
ia
,O
m
an
,E
gy
pt
,J
or
da
n,
So
ut
h
A
fr
ic
a,
Bo
ts
w
an
a,
Y
em
en
Fr
ui
t
an
d
yo
un
g
sh
oo
t
as
fo
od
Le
af
,f
ru
it
,a
er
ia
lp
ar
t,
an
d
st
em
ar
e
us
ed
fo
r
a
va
ri
et
y
of
tr
ea
tm
en
ts
Se
if
u
(2
00
4)
;S
ol
ta
n
an
d
Za
ki
(2
00
9)
;C
he
ro
ua
na
et
al
.(
20
13
);
G
ha
za
nf
ar
(1
99
4)
;H
as
sa
n-
A
bd
al
la
h
et
al
.(
20
13
);
Tr
ab
sa
et
al
.
(2
01
5)
;C
he
rm
at
an
d
G
ha
rz
ou
li
(2
01
5)
;A
lk
uw
ar
i
et
al
.(
20
12
);
Sh
er
an
d
A
ly
em
en
i
(2
01
1)
;G
aw
ee
sh
et
al
.(
20
15
);
Iw
u
(2
01
4)
;
M
PN
S,
20
17
;E
l-G
ha
za
li
et
al
.(
20
10
);
M
ol
la
et
al
.(
20
11
);
D
ah
ec
h
et
al
.(
20
13
)
L.
sh
oc
kl
ey
iA
.G
ra
y
U
S,
M
ex
ic
o
N
M
N
M
–
L.
st
en
op
hy
llu
m
J.
R
ém
y
C
hi
le
,P
er
u,
A
rg
en
ti
na
N
M
N
M
–
L.
st
ra
nd
ve
ld
en
se
A
.M
.V
en
te
r
So
ut
h
A
fr
ic
a
N
M
N
M
–
L.
te
nu
is
pi
no
su
m
S.
B.
Jo
ne
s&
W
.Z
.F
au
st
A
rg
en
ti
na
,C
hi
le
,P
ar
ag
ua
y
N
M
N
M
–
L.
te
nu
is
pi
no
su
m
va
r.
fr
ie
si
i(
D
am
m
er
)
C
.H
.H
it
ch
c.
A
rg
en
ti
na
N
M
N
M
–
L.
te
tr
an
dr
um
Th
un
b.
N
am
ib
ia
,S
ou
th
A
fr
ic
a,
A
ng
ol
a
Fr
ui
t
as
fo
od
N
M
W
at
t
an
d
Br
ey
er
-B
ra
nd
w
ijk
(1
96
2)
;M
PN
S,
20
17
L.
te
xa
nu
m
C
or
re
ll
U
S,
M
ex
ic
o
N
M
N
M
–
L.
to
rr
ey
iA
.G
ra
y
U
S,
M
ex
ic
o
Fr
ui
t
as
fo
od
W
ho
le
pl
an
t
an
d
ro
ot
as
m
ed
ic
in
e,
fo
r
ch
ic
ke
np
ox
an
d
to
ot
ha
ch
e
N
A
EB
(2
00
3)
;F
EI
S
(2
01
6)
;K
ea
rn
ey
et
al
.(
19
60
);
Po
w
el
l
(1
98
8)
;V
in
es
(1
96
0)
;H
od
gs
on
(2
00
1)
;M
PN
S,
20
17
;
Q
ua
tt
ro
cc
hi
(2
01
2)
L.
tr
un
ca
tu
m
Y
.C
.
W
an
g
C
hi
na
N
M
R
oo
t
ba
rk
as
m
ed
ic
in
e
di
gu
pi
Li
et
al
.(
20
01
)
L.
tw
ee
di
an
um
G
ri
se
b.
C
ol
om
bi
a,
Ec
ua
do
r,
D
om
in
ic
an
,T
uk
s
A
nd
C
ai
co
s
Is
la
nd
s,
Ja
m
ai
ca
,B
ol
iv
ia
,B
ah
am
as
,
C
ub
a,
Pa
ra
gu
ay
,
V
ir
gi
n
Is
la
nd
Fr
ui
t
as
fo
od
N
M
R
ot
h
an
d
Li
nd
or
f
(2
00
2)
L.
ve
rr
uc
os
um
Ea
st
w
.
U
S
N
M
N
M
–
L.
vi
llo
su
m
Sc
hi
nz
So
ut
h
A
fr
ic
a,
N
am
ib
ia
,B
ot
sw
an
a
N
M
N
M
–
L.
vi
m
in
eu
m
M
ie
rs
A
rg
en
ti
na
,U
ru
gu
ay
N
M
N
M
–
L.
yu
nn
an
en
se
K
ua
ng
&
A
.M
.L
u
C
hi
na
N
M
N
M
–
a
Sp
ec
ie
s
di
st
ri
bu
ti
on
an
d
va
lid
pl
an
tn
am
e
in
fo
rm
at
io
n
so
ur
ce
s
ar
e
no
ti
nc
lu
de
d,
w
hi
ch
ar
e
ex
tr
ac
te
d
fr
om
:T
he
pl
an
tl
is
t(
20
13
);
IP
N
I(
20
15
);
G
BI
F
(2
01
7)
;e
Fl
or
as
(2
01
7)
;A
fr
ic
an
Pl
an
tD
at
ab
as
e
(C
on
se
rv
at
or
y
an
d
Bo
ta
ni
ca
lG
ar
de
n
of
G
en
ev
a
an
d
So
ut
h
A
fr
ic
an
N
at
io
na
lB
io
di
ve
rs
it
y
In
st
it
ut
e)
,2
01
7;
Eu
ro
Pl
us
M
ed
Pl
an
tB
as
e
(2
01
1)
;F
lo
ra
of
N
or
th
A
m
er
ic
a
(2
00
9)
;V
ic
Fl
or
a
(2
01
5)
;F
lo
ra
of
A
rg
en
ti
na
(1
99
2)
;F
lo
ra
of
Is
ra
el
(2
01
7)
;F
lo
ra
of
C
hi
na
(1
99
4)
.I
fn
o
so
ur
ce
s
ar
e
gi
ve
n,
no
re
fe
re
nc
es
fo
r
th
is
sp
ec
ie
s’
fo
od
or
m
ed
ic
in
e
us
es
.
R. Yao et al. Journal of Ethnopharmacology 212 (2018) 50–66
25
Table 3
Main morphological characters of commonly used Lycium species of all continents.
Species Berry Flower Stem and leaf
L. ruthenicum Murray Purple-black, globose, or emarginate.
Seeds brown.
Pedicel 5–10 mm. 0.2–1 m tall. Stems much branched.
Calyx narrowly campanulate, 4–5 mm, regularly 2–4-
lobed, lobes sparsely ciliate.
Leaves subsessile, solitary on young branches, leaf
blade grayish, succulent, linear or sub-cylindric,
rarely linear-oblanceolate,Corolla pale purple, funnel form, ca. 1.2 cm; lobes
oblong ovate, 1/3-1/2 as long as corolla tube, not
ciliate.
L. truncatum Y.C. Wang Red or orange-yellow. Oblong or oblong-
ovoid, mucronated. Seeds orange.
Pedicel 1–1.5 cm. 1–1.5 m tall, sparingly armed. Branches ﬂexible.
Calyx campanulate, 3–4 × 3 mm, 2- or 3- lobed or
truncate, sometimes circumscissile and only base
persistent.
Leaves solitary on long shoots, clustered on short
shoots; leaf blade linear-lanceolate or lanceolate.
Corolla purple or reddish purple, tube ca. 8 mm; lobes
ca. 4 mm, not ciliate.
L. dasystemum Pojark. Red, ovoid, or oblong. Pedicel 1–1.8 cm. ca. 1.5 m tall. Stems much branched; branches
grayish white, yellowish, or rarely brown-red,
stout, young branches slender, elongate.
Seeds more than 20. Calyx campanulate, ca. 4 mm, often 2- or 3-divided
halfway. Corolla purple, funnelform, 0.9–1.3 cm; tube
sparingly villous inside; lobes ovate, half as long as
corolla tube, ciliolate.
Leaf blade lanceolate, oblanceolate, or broadly
lanceolate.
L. barbarum L. Red or orange-yellow, oblong or ovoid,.
Seeds usually 4–20, brown-yellow, ca. 2
mm.
Pedicel 1–2 cm. 0.8–2 m tall. Stems and branches glabrous,
branches thorny.Calyx campanulate, 4–5 mm, usually 2-lobed, lobes 2-
or 3-toothed at apex.
Corolla purple, funnelform; tube8-10 mm, obviously
longer than limb and lobes; lobes 5–6 mm, spreading,
margin glabrescent.
Leaves solitary or fasciculate, lanceolate or long
elliptic
L. cylindricum
Kuang & A. M. Lu
Berry ovoid. Seeds few. Pedicel ca.1 cm. Branches inﬂexed, with thorns 1–3 cm.
Calyx campanulate, ca.3×3 mm, usually (2-or) 3-
divided to halfway, lobes sometimes with irregular
teeth.
Corolla tube cylindric, obviously longer than lobes, 5-
6mm, ca. 2.5 mm in diam.; lobes broadly ovate, ca. 4
mm, margin pubescent.
Leaves solitary or in clusters of 2 or 3 on short
shoots; leaf blade lanceolate, base cuneate, apex
obtuse.
L. chinense Mill. Red, ovoid or oblong. Seeds numerous,
yellow, 2.5–3 mm.
Pedicel 1–2 cm. 0.5–2 m tall. Stems much branched; branches pale
gray, slender, curved or pendulous, with thorns
0.5–2 cm.
Calyx campanulate, 3–4 mm, 3–5-divided to halfway,
lobes densely ciliate.
Corolla pale purple, 0.9-l.2 cm; tube funnel-form,
shorter than or subequaling lobes, lobes pubescent at
margin.
Leaves solitaryor in clusters of 2–4; leaf blade
ovate, rhombic, lanceolate, or linear-lanceolate.
L. yunnanense
Kuang & A.M. Lu
Globose, yellow-red when ripe, with an
obvious longitudinal furrow on drying.
Seeds ca. 20, pale yellow, orbicular,
pitted.
Pedicel 4–6 mm. ca. 0.5 m tall. Branch lets yellow-brown, thorny at
apex.
Calyx campanulate, ca. 2 mm, usually 3-lobed or 3- or
4-dentate, tomentose at apex.
Leaves solitary on long shoots, sometimes on
thorns or fasciculate on tubercular short shoots;
petiole short; leaf blade narrowly ovate to
lanceolate, base narrowly cuneate, apex acute.
Corolla pale blue-purple, purple, or occasionally
white, funnel form, 5–7 mm; tube 3–4 mm; lobes 2–3
mm, glabrescent.
L. europaeum L. Reddish Flowers solitary or in c1usters of 2(−3). Calyx 2–3
mm, 5-dentate or 2-lipped. Corol1a 11–13 mm,
narrowly infundibuliform, pink or white; lobes 3–4
mm. Stamens usually exserted; ﬁlaments glabrous,
somewhat unequa1.
1–4 m tall; branches rigid, very spiny; spines stout.
Leaves 20–50×3–10 mm, usually oblanceolate.
L. intricatum Boiss. Orangc-red or black Plant Flowers solitary or in c1usters of 2–3. Calyx
1.5–2 mm, shallowly 5-dentate. Corolla 13–18 mm,
narrowly infundibuliform, blue-violet, purple, lilac,
pink or white; lobes 2–3 mm. Stamens inc1uded;
ﬁlaments glabrous.
0.3–2 m, much-branched, very spiny; spines stout,
rigid. Leaves 3–15×1–6 mm, oblanceolate.
L. afrum L. Purplish Calyx 5–7 mm, deeply 5-dentate. Corolla 20–22 mm,
subcylindrical, purplish-brown; lobes ca. 2 mm.
Stamens included; ﬁlaments with dense tuft of hairs
at base.
1–2 m; branches rigid, very spiny; spines stout.
Leaves 10–23 ×1–2 mm, very narrowly
oblanceolate.
L. berlandieri Dunal Red, globose to ovoid, glabrous. Solitary or in pairs, pedicels 3–20 mm long; calyx
cup-shaped, 1–2 mm long, (3)4- or 5-1obed, the lobes
usually shorter than the tube, glabrous except for a
tuft of hair at the tip of each lobe; corolla blue, pale
lavender, or ochroleucous, campanulate-funnelform,
6–7 mm long, the limb 4- or 5-1obed.
Erect shrub to 2.5 m tall, armed with needlelike
spines on the younger shoots or nearly unarmed;
branches somewhat crooked, glabrous. Leaves 1–3
in a fascicle, linear to elliptic-spatulate, glabrous,
apex rounded to acute, margins entire, base
attenuate to a short petiole or subsessile.
L. pallidum Miers Red (drying blackish or purplish),
glaucous, subglobose to ovoid, glabrous.
Seeds yellowish, widely ovate to
subreniform, minutely pitted.
Solitary or occasionally in pairs, pedicel 8–18 mm
long; calyx campanulate, 5–9 mm long, 5-1obed, the
lobes about equaling or slightly longer than the tube,
glabrous; corolla greenish-white, sometimes tinged
with purple, funnelform, 15–20 mm long, the limb 5-
1obed.
Upright-spreading, much-branched shrubs to
20 dm tall, branches lightly pubescent to glabrous,
sparingly armed with stout spines. Leaves mostly
fascicled, except on young growth; blade
oblanceolate or spatulate, 1–4 cm long, (3)5–15
mm wide, glabrous, apex acute to obtuse, margins
entire, base attenuate; petiole 5–10 mm long.
(continued on next page)
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Levin et al., 2011; GBIF, 2017). It was ﬁrst published by Linnaeus, and
three species (viz. L. europaeum, L. barbarum, and L. afrum) were described
in Species Plantarum (Linnaeus, 1753). In 1932, Hitchcock published a
systematic taxonomic study on 43 Lycium species from the western
hemisphere based on morphology (Hitchcock, 1932). Recently, molecular
markers of diﬀerent genome parts were used to elaborate the phylogenetic
relationship within the genus as well as biogeographic events: Lycium
originated from the Americas, and then dispersed to Africa and Eurasia;
the diversity centers are the Americas and Africa (Olmstead et al., 1999;
Fukuda, 2001; Miller, 2002; Yin et al., 2005; Levin and Miller, 2005; Levin
et al., 2009a, 2009b; Miller, 2011; Levin et al., 2011).
According to our ﬁndings, at present ninety seven species and six
varieties are recognized (Table 2). Among them, 32 are native to South
America, 24 to North America, 24 to Africa, and 12 to Eurasia; two
occur in Eurasia as well as Africa. Lycium australe is the only species
endemic to Australia, and L. sandwicense is native to the Paciﬁc islands.
L. carolinianum occurs in North America as well as the Paciﬁc islands.
Lycium species are shrubs or small trees, often with thorns on the
stem and simple, entire leaves. Usually they are diﬀerentiated through
the thorn on the stem, the shape and size of leaves, the corolla length,
the length of stamen, colour of the fruit, the taste of the fruits, and the
size and number of seeds. Morphological characters of the typical fre-
quently used species of diﬀerent continents are summarized in Table 3.
However, the commercial Lycium products are always without these
characteristic traits as they are only few parts of the plant, e.g., fruit,
root bark and leaf, therefore, morphological techniques solely were not
suﬃcient for the authentication of Lycium products. For example, fruits
of L. barbarum and L. chinense, the two most commonly used goji, are
diﬃcult to distinguish by eye (Xin et al., 2013), which is a challenge for
quality assessment in trading.
3.2. Traditional uses
3.2.1. Traditional uses worldwide
Of all 97 species, 35species and 2 varieties were found to be used as
food and/or medicine (Table 2). The number of native species of the
diﬀerent continents used as food and medicine are shown in Fig. 1.
Although the richness of Lycium species diﬀers in South America,
North America, Africa and Eurasia, the numbers of species used are
similar. Therefore, the species use ratios are dramatically diﬀerent. In
Eurasia, nine (64%) of the 14 species, and one variety, are used. While
86% of the Lycium species occur in the Americas and Africa, only 31%
(26 species) of them are used as food and/or medicine. The Australian
species as well as the two Paciﬁc Island species are all used as food.
Of 28 species the plant parts used are the fruits, both for food and
medicine, indicating that the fruit is worldwide the most commonly
used plant part; of the other species also the leaves and root bark are
used, and in some cases the whole plant. Leaves and root bark are
usually used as medicine, while young shoots may also be prepared as
food. Lycium barbarum, L. chinense, and L. ruthenicum are the most often
reported species in the literature for China, L. europeaum, L. intricatum,
and L. shawii for the Mediterranean and Middle East, L. pallidum for
North America, and L. afrum for Africa. Usually the fresh or dried fruits
are consumed, and the fresh leaves are cooked as food or used as tea. Of
them, L. barbarum and L. chinense have been introduced as “superfood”
from China to Europe, the Americas, and Australia. They are typically
consumed as food supplement.
3.2.2. Use of Lycium in China over time
Today, the dried fruits and the root bark of L. chinense and L. bar-
barum, called Gouqi Zi and Digu Pi, are commonly used in Chinese
medicine and diet (Wagner et al., 2011; Chang and So, 2015; Tan et al.,
2017). Whether the same or diﬀerent species have been used in the past
is not easy to deduce from the historical herbals, as the species concept
did not exist in earlier times; and in the older herbals, even the plant
parts used were not recorded. Therefore, information has to be inferred
from the Chinese characters and the plant ﬁgures in the historical
herbals.
The Chinese characters “枸杞” (gǒu qǐ) means Lycium, although
sometimes the word means the fruit of Lycium only. However, in the
ancient literature the character “杞” alone was often referring to
Lycium. “杞” was also present in the oracle bone script, a script which
was used in Shang Dynasty (B.C.E. 1400 s to B.C.E. 1100 s), indicating
that the use of Lycium has a long history in China. It also appeared in
later scripts, like bronze inscription and seal script. The earliest record
of using Lycium in China was found in the Book of Songs (诗经，shī
jīng), which consisted of poems written in the Zhou Dynasty (B.C.E.
1100 s to B.C.E. 300 s) (Gao, 1980). In the 74 poems of the chapter
Xiaoya (小雅，xiǎo yǎ), “杞” was mentioned six times. The sentences,
“南山有杞 (nán shān yǒu qǐ)” and “言采其杞 (yán cǎi qí qǐ)”, describe
people harvesting Lycium plants growing in the mountains.
Records of Lycium in the Chinese herbals over time are listed in S1,
while Fig. 2 shows Lycium illustrations. The earliest record of Lycium as
medicine was in Shennong's Herbal (ca. C.E. 100) (Shang, 2008). The
original herbal does not exist anymore, and the present edition was
compiled from later citations. The text mentions the ﬂavour, eﬀects,
common names, and habitat of Lycium brieﬂy, but not the plant parts
used (Li, 1954). Deduced from the given ﬂavour, it might be the root;
from the eﬀects, it could be both fruits and roots; from the recorded
common name “枸杞”, it might be both fruits and roots, as some later
herbals also used the same name for root and/or fruit.
In the Jin Dynasty (C.E. 266− 420), Ge Hong (284− 364) published
two herbals, Baopuzi (Ge, 1995) and Zhouhou Beiji Fang (Ge, 1999), both
of which included Lycium. The later was the ﬁrst herbal with formulas,
and Lycium fruit, root, and juice were recorded separately in diﬀerent
formulas. Leigong Paozhi Lun (ca. 420 − 479) (Lei, 1985), the ﬁrst
monograph on processing of materia medica, recorded the manufacture of
the root bark, while the fruit decoction was used for processing another
drug. Mingyi Bielu (Tao, 1986), published around C.E. 500, is commonly
regarded as the ﬁrst herbal describing the use of Lycium fruits; however,
according to our research, Lycium fruits and root had already been used
separately in earlier times (Jin Dynasty by Ge Hong).
Lycium was ﬁrst recorded as food in Bencaojing Jizhu (ca. C.E. 500)
(Tao, 1994). In Xinxiu Bencao (659) (Su, 1981) and Shiliao Bencao (ca.
700) (Meng, 1984), Lycium was also recorded as food, with several
medicated diet recipes of the fruits, root, and leaves. Later, in Qianjin
Yifang (682) (Sun, 1998), cultivation techniques of Lycium were de-
scribed, beside its medicinal usages.
New in the Song Dynasty (960 − 1279) was the detailed morpho-
logical description of the plant accompanied by illustrations. Bencao
Table 3 (continued)
Species Berry Flower Stem and leaf
L. shawii Roem. & Schult. Orange-red, 4 mm broad. Seeds ca. 1.5
mm broad, reniform, brown.
Solitary or paired, white or purple-suﬀused. Pedicel
3–4 mm long, pilose. Calyx narrow tubular, pilose;
lobes 0.5–1 mm long, acute, pubescent. Corolla tube
10–12 mm long; lobes 2.0 mm long, acute, minutely
pubescent. Filaments glabrous at the base,
subexserted.
A spiny branched shrub 100–180 cm tall, shoots
white-tomentose. Spines tomentose towards the
base. Leaves 4–25 (−30) × 2.5–6 mm, elliptic-
oblong to narrow oblong, cuneate, obtuse or acute,
pilose to tomentose.
Flora of China Editorial Committee (1994), Tutin (1972), McGregor and Barkley (1986) and Ali (1980).
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Tujing (Su, 1994) and Zhenglei Bencao (Tang, 1982) were the most im-
portant herbals during Song, and Lycium was recorded in both.
In the Yuan Dynasty (1271 − 1368), the recipes of tea, porridge,
and wine using the fruit or the leaves were recorded in the medicated
diet monograph Yinshan Zhengyao (Hu, 2009).
Bencao Gangmu (1596) (Li, 1954), also known as Compendium of
Materia Medica, discussed the habitat, the use history, manufacturing,
and usage of Lycium, oﬀering a review of former information as well as
Li Shizhen's (1518 − 1593) understanding of its use. In the Ming and
Qing Dynasty (1644 − 1912), many formulas containing Lycium
emerged and were described in various herbals. In 1935, the herbal
Zhongguo Yaoxue Da Cidian (Chen, 1935), for the ﬁrst time published
the scientiﬁc name Berberis lycium for枸杞. This was later found to be a
misidentiﬁcation, and was replaced by Lycium. Besides the key herbals
described above, there were still many interesting ones published in
diﬀerent times (Chen, 1985, 1988, 2008; Du, 1975; Jiang, 1911; Kou,
1990; Liu, 1956; Lu, 1986; Ni, 2005; Wang, 1987; Wu, 1959, 1987; Yan,
1958; Yang, 1958; Zhu, 2008); as a result, these herbals conserved the
food and medicine use history of Lycium in China.
The contemporary herbals, such as Zhonghua Bencao (Zhonghua
Bencao Editorial Board, 1999), Xinbian Zhongyao Zhi (Xiao, 2002), and
Zhongyao Da Cidian (Nanjing TCM University, 2006), refer to both L.
chinense and L. barbarum. Precise botanical descriptions are provided
and usages are combined with scientiﬁc ﬁndings and pharmacological
evidence and guidance for use.
3.2.3. Traditional uses by Chinese ethnic minorities
In China, seven species and two varieties of the genus Lycium occur,
of which four species have been used by diﬀerent ethnic groups. We
found use records for twelve of the oﬃcially recognized 55 ethnic
Fig. 1. Lycium species used as food and/or medicine
on the diﬀerent continents.
Fig. 2. Illustrations of Lycium in Chinese herbals over time.
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minorities of China (Table 4).
Four species have been used in Tibetan medicine, while both L.
barbarum and L. chinense by the Uighurs and either of them by the other
ethnic groups. Fruits as well as root bark and leaves have been com-
monly used. The whole plant has been used by the Miao and Yi for
diﬀerent purposes: Miao use it as a tonic, while Yi use it for sores and
itching. The Miao's usages are similar to the ancient Chinese herbals’
records.
In general, Lycium spp. have often been used for the treatments of
blurry vision, fever, night sweat, kidney deﬁciency, cough and asthma,
diabetes, heart diseases, gynecopathy, and neurasthenia. However, the
Yi and Dong use them diﬀerently, i.e. the fruits of L. chinense are for
bleeding gums, while the whole plant as antipruritic drug. They were
also used as medicinal food by the Miao and Yi.
3.2.4. Comparison of traditional uses with recent pharmacological studies
Diﬀerent Lycium species, foremost L. barbarum and L. chinense, were
phytochemically analyzed and hundreds of compounds were isolated
and identiﬁed (Qian et al., 2017). Bioactivities and pharmacological
eﬀects of crude extracts or compounds were assessed in pharmacolo-
gical studies and it turns out that many of the traditional uses are
supported by these studies. For example, the anti-aging eﬀect of Lycium
(probably the whole plant of L. chinense or L. barbarum) has been re-
corded since Shennong's Herbal (ca. C.E. 100); recent studies demon-
strated that polysaccharides, vitamins, pigments, and crude extracts of
Lycium fruits are beneﬁtting age-related lesions (Bucheli et al., 2011; Li
et al., 2007; Kim et al., 1997; Tao et al., 2008; Yi et al., 2013). Use for
improving eyesight was mentioned in herbals as well, and Zeaxanthin,
lutein, and polysaccharides were found to have retinal protection ac-
tivities (Tang et al., 2011; Mi et al., 2012b; Song et al., 2012; Chu et al.,
2013; Pavan et al., 2014). Xiaoke is a term used in ancient herbals,
describing symptoms similar to present diabetes (Li et al., 2004); Stu-
dies on root bark and fruits of L. chinense and L. barbarum found that
water extract, polysaccharides, organic acids, and alkaloids have an
eﬀect on lipid metabolism and oxidative restoring of diabetic animals
(Ye et al., 2008; Li, 2007; Luo et al., 2004). Also, an anti-fatigue and
hepatoprotective eﬀect of Lycium fruits and root bark has been shown
recently (Alharbi et al., 2017; Xiao et al., 2012; He et al., 2012; Cui
et al., 2012), and has been recorded in herbals too.
Since L. barbarum and L. chinense are widely used species, most
phytochemical and pharmacological studies have been focusing on the
fruits and root bark of these two species. As a result, there are scientiﬁc
evidences for their medical use, which in turn have been increasing
again their popularity. Therefore, they have been adopted in pharma-
copoeias of many countries and regions. For example, in the current
Chinese pharmacopoeia (2015), there are 75 prescriptions containing
fruits of L. barbarum. They were also allowed to be used as cosmetic
materials in China. In contrast, only a few studies focused on other
Lycium species, which are less widely used (Table 5).
3.3. Lycium in current pharmacopoeias
3.3.1. Lycium in recent pharmacopoeias of the world
As sources of common herbal medicines, Lycium species have been
incorporated into several pharmacopoeias, including China, Europe,
Japan, Korea, Taiwan, UK, and Vietnam (Table 6). Lycium has not been
included in the pharmacopoeia of USA, Russia, Africa, Australia, Brazil,
Argentina, Switzerland, Iran, and India.
The fruit and/or root bark of L. barbarum and/or L. chinense are the
most frequently used materials mentioned in the pharmacopoeias, al-
though the aerial part of L. barbarum and L. europeaum are recorded by
the Indian Ayurveda pharmacopoeia. The European pharmacopoeia
only includes the dried fruit of L. barbarum.
Lycium fruits (Lycii Fructus) and Lycium root bark (Lycii Radices
Cortex) are used in several regions oﬃcially, however, the quality cri-
teria diﬀer. Firstly, the species used as Lycii Fructus diﬀer. LyciumTa
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Table 5
General bioactivities of compounds or extracts of Lycium spp.
Bioactivity Compounds, extracts, or plant materials References
Antioxidant Flavonoids, polysaccharides, pigments, mixed extracts,
fatty acid
Le et al. (2007); Li and Zhou (2007); Li et al. (2007); Bai et al. (2008); Donno et al. (2015);
Benchennouf et al. (2017); Wang et al. (2010); Chung et al. (2014)
Spermatogenesis Polysaccharides (fruit of L. barbarum) Luo et al. (2014); Qian and Yu (2016); Shi et al. (2017)
Retinal protection Zeaxanthin and/or lutein, polysaccharides Tang et al. (2011); Mi et al. (2012b); Song et al. (2012); Chu et al. (2013); Pavan et al. (2014)
Hepatoprotective Zeaxanthin dipalmitate, polysaccharides, betaine,
ﬂavonoids, fruit
Alharbi et al. (2017); Xiao et al. (2012); Xiao et al. (2014b); Xiao et al. (2014a); Zhang et al.
(2010); Ahn et al. (2014); Ha et al. (2005)
Anti-aging Fruit, polysaccharides, vitamins, pigments Bucheli et al. (2011); Li et al. (2007); Kim et al. (1997); Tao et al. (2008); Yi et al. (2013)
Immunomodulation Polysaccharides-protein complex, polysaccharides,
pigments
Zhang et al. (2014); Tang et al. (2012); Chen et al. (2012); Chen et al. (2008); Chen et al.
(2009a), (2009b); Xie et al. (2016); Gan et al. (2004)
Anti-tumor Polysaccharides-protein complex, polysaccharides, mix
extract, scopoletin and AA−2βG
He et al. (2012); Cui et al. (2012); Tang et al. (2012); Hu et al. (1994); Gan et al. (2004); Liu
et al. (2000)
Skin care Polysaccharides, juice, glycoconjugate Reeve, et al., 2010; Liang and Zhang (2007); Zhao et al. (2005)
Anti-microbial Lyciumoside I, AcOEt-soluble fraction Terauchi et al. (1998); Lee et al. (2005); Kim et al. (2000)
Anti-diabetic Water extract, polysaccharides, organic acids, and
alkaloids
Ye et al. (2008); Song et al. (2012); Li et al. (2004); Li (2007); Jia et al. (2003); Luo et al.
(2004)
Anti-atherosclerosis Seed oil, polysaccharides Jiang et al. (2007); Ma et al. (2009)
Hypotensive Water extract, polysaccharides Kim et al. (1997); Mi et al. (2012a); Mi et al. (2012b)
Neuroprotective Water extract, polysaccharides, alkaline extract Ho et al. (2007); Chan et al. (2007);Ho et al. (2010); Mi et al. (2013); Wang et al. (2014)
Anti- fatigue Polysaccharides, betaine Wu and Guo (2015); Kim and Baek (2014)
Table 6
Lycium records in current pharmacopoeias of the world.
Region Pharmacopoeia Species Used parts Description Identiﬁcation Examination
China Chinese
Pharmacopoeia
(Pharmacopoeia
Commission, 2015)
L. barbarum Fruit Harvest, process, air dry,
odour, taste,
macroscopic, storage,
indication
Microscopic, TLC Loss on drying ≤ 13.0%, total ash ≤ 5.0%, water extract
content≥ 55%, polysaccharides≥ 1.8%, betaine≥ 0.30%,
heavy metals
L. barbarum/ L.
chinense
Root bark Yinpian; harvest, process,
odour, taste,
macroscopic, storage,
indication
Microscopic, TLC Loss on drying≤ 11%, total ash≤ 11%, acid-insoluble ash
≤ 3%
EU European
Pharmacopoeia (9.0)
(2016)
L. barbarum Fruit Dried, whole, ripe fruit Macroscopic,
microscopic, TLC
Loss on drying ≤ 13%, total ash ≤ 5%, extract content ≥
55%
UK British
Pharmacopoeia
Commision (2017)
L. barbarum Fruit Dried, whole, ripe fruit Macroscopic,
microscopic, TLC
Loss on drying ≤ 13%, total ash ≤ 5%, extract content ≥
55%
Japan Japanese
Pharmacopoeia
(17th)(2016)
L. barbarum/ L.
chinense
Fruit Morphologic, odour,
taste, storage
TLC Foreign matters ≤ 2%, total ash ≤ 8%, acid-insoluble ash
≤ 1%, extract content (dilute ethanol) ≥ 35%
L. barbarum/ L.
chinense
Root bark Morphologic, odour,
microscopic, taste,
storage
TLC Heavy metals, arsenic, loss on drying≤ 11.5%, total ash≤
20%, acid-insoluble ash ≤ 3%, extract content (dilute
ethanol) ≥ 10%
Korea Korean
Pharmacopoeia
(11th)(2014)
L. barbarum/ L.
chinense
Fruit Morphologic, odour,
taste
TLC Foreign matters ≤ 3%, total ash ≤ 6%, betaine ≥ 0.5%.
L. barbarum/ L.
chinense
Root bark Morphologic,
microscopic
Colour test, TLC Loss on drying ≤ 12%, foreign matters ≤ 5%, total ash ≤
18%, acid-insoluble ash ≤ 3%, extract content(dilute
ethanol) ≥ 8%
Korean
Pharmacopoeia (9th)
(2007) (Korea Food
and Drug
Administration,
2007)
L. barbarum/ L.
chinense
Fruit Morphologic, odour,
taste
Colour test Foreign matters ≤ 3%, total ash ≤ 6%, betaine ≥ 0.5%.
L. barbarum/ L.
chinense
Root bark Morphologic,
microscopic
Colour test, TLC Loss on drying ≤ 12%, foreign matters ≤ 5%, total ash ≤
18%, acid-insoluble ash ≤ 3%, extract content(dilute
ethanol) ≥ 8%
Taiwan Taiwan TCM
Pharmacopoeia
(2nd)(2013)
L. barbarum/ L.
chinense
Fruit Macroscopic, indication,
microscopic, storage
TLC Total ash ≤ 11%, acid-insoluble ash ≤ 2%, aﬂatoxin ≤
15.0 ppb, extract content (dilute ethanol ≥ 35%, water
≥40%)
L. barbarum/ L.
chinense
Root bark Macroscopic,
microscopic, storage,
indication
TLC Loss on drying≤ 14%, total ash≤ 15%, heavy metal≤ 10
ppm, As ≤ 6 ppm, extract content (dilute ethanol ≥ 8%,
water ≥ 10%)
Vietnam Vietnam
Pharmacopoeia (4th)
(2007) (Ministry of
Health, 2010)
L. barbarum Fruit Macroscopic,
microscopic, process,
storage, indication
TLC Loss on drying ≤ 11.0%, total ash ≤ 5.0%, extract content
≥ 55%, foreign matters ≤ 1%
L. barbarum/ L.
chinense
Root bark Macroscopic,
microscopic, process,
storage, indication
Macroscopic,
microscopic, TLC
Loss on drying ≤ 11%, foreign matter ≤ 2%, total ash ≤
11%
India Ayurveda API (Vol.
6) (Department of
Ayush New Delhi,
2008)
L. barbarum/ L.
europeaum
Aerial part Macroscopic,
microscopic
TLC Foreign matters≤ 2%, total ash≤ 15%, acid-insoluble ash
≤ 2%, extract content (dilute ethanol ≥ 4.5%, water ≥
20%)
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chinense is accepted by the pharmacopoeias of Japan, Korea, and
Taiwan, but not included in the pharmacopoeias of China, Europe, UK,
and Vietnam; while they are not morphologically distinguishable,
practically, both of them are consumed widely. Secondly, the descrip-
tions are diﬀerent. Indications are only included in pharmacopoeias of
China, Taiwan, and Vietnam; macroscopic and microscopic traits are
included to diﬀerent degrees. Thirdly, the identiﬁcation techniques
diﬀer. Colour test as primary identiﬁcation tool, which could be used
for detecting some chemical groups, is only used by the Korean phar-
macopoeia; TLC, which is much more speciﬁcity based on chemical
ﬁngerprint and suﬃcient for species diﬀerentiation, is used widely.
However, it was not included in the Korean pharmacopoeia until 2012.
Lastly, the quality examination indexes and their thresholds diﬀer as
well. While betaine, a bioactive compound in Lycii Fructus, is used as
index in the pharmacopoeia of China and Korea only, contents of
polysaccharides are exclusively mentioned in the Chinese one.
3.3.2. Lycium in Chinese pharmacopoeias
Since 1949, there have been 10 editions of the Chinese pharmaco-
poeia (Chinese Pharmacopoeia Commission, 1963, 1977, 1985, 1990,
1995, 2000, 2005, 2010, 2015). Lycium species described in the dif-
ferent editions are shown in Table 7.
Lycium was not included in the ﬁrst edition of the Chinese phar-
macopoeia which was published in 1953. While in 1963 L. barbarum
and L. chinense were mentioned for their fruits and L. chinense for its
root bark. This changes afterwards and L. barbarum was documented for
its fruits while both, L. chinense and L. barbarum were used for their root
barks.
The descriptions of Lycii Fructus and Lycii Radices Cortex of all edi-
tions were similar, but macroscopic traits became more and more de-
tailed over time. Identiﬁcation and examination indexes, however,
changed greatly. In the 1963 edition, the identiﬁcation was based on
macroscopic traits only, later, microscopic, total ash, TLC, loss on
drying, impurities, contents of extracts, acid-insoluble ash, and heavy
metals were included in succession. The development of pharmaco-
poeial monographs indicates the progress of quality control of herbal
medicines.
Besides the pharmacopoeia, there are still some regional medicinal
criteria which are published by provinces of China. Since the environ-
ments and the customs may diﬀer among provinces, the records are
diverse. For example, in Ningxia, the pedicel of the fruit and leaves of L.
barbarum are oﬃcially used; in Xinjiang, the fruit of L. dasystemum has
been accepted; in Gansu, the root bark of L. truncatum has been an of-
ﬁcial source of Lycii Radices Cortex (Li, 2001).
Accordingly, in China the quality criteria of Lycii Fructus and Lycii
Radices Cortex have experienced notable developments over time, and
they vary by geographic regions.
3.3.3. Comparison of Lycium records among pharmacopoeias
As demonstrated above, the fruits and/or root bark were adopted by
pharmacopoeias of many countries and regions, as well as Chinese
pharmacopoeias of diﬀerent times; however, the descriptions and
quality requirements were diﬀerent. In order to understand the re-
lationship of these pharmacopoeias, we extracted the parameters which
were used for the identiﬁcation of Lycium. The Indian Ayurveda phar-
macopoeia was not included as it describes the aerial parts of the plant
as a medicine, and the Chinese pharmacopoeia 1953 was excluded since
it does not record Lycium. The results are shown in Fig. 3.
By the parameters of fruit, pharmacopoeias are ﬁrstly categorized
into two groups: those of Taiwan, Japan, and Korea are with the earlier
editions of Chinese pharmacopoeia, while European pharmacopoeia 9.0
(shown as EU 2016), British Pharmacopoeia Commision (2017) (UK
2017, which is the same as EU 2016), and Vietnam pharmacopoeia IV
(shown as VN 2007) are similar to the later editions of Chinese phar-
macopoeias (2000–2015). The diﬀerence between KR 2007 and KR
2014 is that the later includes TLC as an identiﬁcation technique, and
they have a lower similarity with others. Pharmacopoeia of Taiwan and
Japan are closely related and are separated from the earlier Chinese
editions. The clustering also shows the development of Chinese phar-
macopoeias over time: the ones before 2000 are separated from the
ones since 2000; the reason is probably that the later include more
examination items such as moisture and total ash.
By the data of root bark, EU 2016 and UK 2017 are separated from
others since it does not adopt root bark. Pharmacopoeias of Taiwan,
Japan, and Korea are in the same branch excluded from the Chinese
ones. Like the result from the fruit, pharmacopoeias of Taiwan and
Japan are again in the same group; VN 2007 is similar to the later
Chinese ones since 2000 (except for the 2005 edition). If we consider
the Chinese ones, the development is also presented by the clustering.
However, the one of 2005 is grouped with the earlier ones; this may be
because TLC was omitted.
Accordingly, the clustering is a practical tool to study the devel-
opment of pharmacopoeia over time, as well as to reveal the relation-
ship among pharmacopoeias of diﬀerent regions.
4. Discussion
According to our study, 35 out of 97 Lycium species worldwide have
been recorded to be used as food and / or medicine. The species use
ratio in the Americas is rather low, maybe because there are many
species available there. Alternatively, it would be worth to investigate
the abundance of diﬀerent species in the relevant regions in order to
better understand the potential access to these resources. The thorny
Lycium species are generally ignored. In order to make better use of less-
used Lycium species, phytochemical and pharmacological studies are
needed.
Only L. barbarum and L. chinense have been transformed into glob-
ally traded commodities and are marketed worldwide as a “super food”.
In China, based on the Chinese name “枸杞” their use can be traced
back over the last two millennia. However, identiﬁcation of the plant
species and plant parts used is often not possible with certainty.
Nevertheless, the use of Lycium fruits for anti-aging, improving eyesight
and nourishing can be traced back at least C.E. 500 in Mingyi Bielu, and
these usages still continue until today in Chinese medicine.
The diversity of plant usages oﬀers opportunities for the develop-
ment of new food and or medicine products. However, challenges for
the quality control will have to be overcome. According to our study,
diﬀerent parts of Lycium species are used, and both of the botanical
resources and traditional knowledge are primary materials for devel-
oping traditional herbal products (Jütte et al., 2017; Tu, 2015; Ngo
et al., 2013). On the other hand, those diﬀerences set obstacles with
regards to the quality control of the products, and the quality criteria
diﬀer greatly among regions. Along with the popularity of the fruits of
L. barbarum and L. chinense, they become global consumables. However,
almost all the goji are produced in China, and the exporters have to
adjust their products to meet the diverse quality requirements of dif-
ferent regions; the diﬀerent quality criteria among regions will prob-
ably obstruct the international trading. Therefore, a relative uniform
quality criterion is recommended.
In general, recent pharmacological ﬁndings on L. barbarum and L.
chinense largely support traditional uses as described in ancient herbals.
Especially polysaccharides, zeaxanthin dipalmitate, vitamins, betaine,
and mixed extracts were reported to be responsible for anti-aging, im-
proving eyesight, anti-fatigue eﬀects. It is obvious that detailed phar-
macognostical studies lay a solid foundation for the wide acceptance of
the plants and their products. Therefore, researches also need to focus
on those less well-studied species but with interesting biological ac-
tivities (Yao et al., 2011; Qian et al., 2017) as potential new sources of
(healthy) foods or medicines. Due to the complexity of herbal pre-
parations, quality control using only few chemical indicators is in-
suﬃcient. Instead, the metabolomic approaches need to be developed
(Donno et al., 2016).
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Historical documentary evidences are good basis for ethnobotanical
study (Heinrich et al., 2006, 2012; Jütte et al., 2017). The historical
continuity of Chinese medical herbals showcase the evolution of peo-
ples’ medical knowledge and oﬀer ideas for treatment options for cur-
rent diseases. In this study, the use history of Lycium in China was
mapped out using the herbals, and some of the reported eﬀects in-
volved, such as anti-aging, retinal protection, and anti-fatigue, have
been demonstrated experimentally. However, there are gaps between
the descriptions in Chinese herbals and modern concepts: 1) the species
are often not properly described as most of them were not written by
botanists but doctors; 2) the terms of diseases and the description of
symptoms are diﬃcult to understand because of the diﬀerence of
medical concepts; 3) the herbals contain historical “clinical data” and
both the right and inaccurate information are included. As a result, the
herbals are important sources of medicinal and nutritional researches,
but they need to be used dialectically.
5. Conclusions
A comprehensive understanding of a species' characteristics, which
includes taxonomy, geographic distribution, traditional use, phy-
tochemistry, pharmacology, knowledge evolution, and quality control,
is indispensable for ﬁnding new sources for food and/or medicine. This
article highlights the need for a very sound understanding of the multi-
contextual basis of what is commonly termed a species ‘traditional use’.
The research approach used had to be transdisciplinary and the in-
tegration of historical, modern ethnobotanical, botanical, phytochem-
ical and pharmacological data has enabled a much more detailed un-
derstanding of the genus as a whole and its wider potential. It also
highlights that the focus so far has only been on two species and that
the genus can potentially yield a wide range of other products with
diﬀerent properties.
This research has relied heavily on historical documentary evi-
dences and such sources are good starting points for ethnopharmaco-
logical studies. In the present work, a set of time-continuous historical
herbals of Chinese medicine generated a database on its usage and has
allowed us to better understand the evolution of knowledge about
Lycium. Hopefully, this ethnobotanical review incorporating both space
and time dimensions will serve as a model for studying traditional food
or medicine plants.
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Goji (fruits of Lycium barbarum L. and L. chinense Mill.) has been used in China as food
and medicine for millennia, and globally has been consumed increasingly as a healthy
food. Ningxia, with a semi-arid climate, always had the reputation of producing best
goji quality (daodi area). Recently, the increasing market demand pushed the cultivation
into new regions with different climates. We therefore ask: How does goji quality differ
among production areas of various climatic regions? Historical records are used to
trace the spread of goji production in China over time. Quality measurements of 51
samples were correlated with the four main production areas in China: monsoon (Hebei),
semi-arid (Ningxia, Gansu, and Inner Mongolia), plateau (Qinghai) and arid regions
(Xinjiang). We include morphological characteristics, sugar and polysaccharide content,
antioxidant activity, and metabolomic profiling to compare goji among climatic regions.
Goji cultivation probably began in the East (Hebei) of China around 100 CE and later
shifted westward to the semi-arid regions. Goji from monsoon, plateau and arid regions
differ according to its fruit morphology, whereas semi-arid goji cannot be separated
from the other regions. L. chinense fruits, which are exclusively cultivated in Hebei
(monsoon), are significantly lighter, smaller and brighter in color, while the heaviest and
largest fruits (L. barbarum) stem from the plateau. The metabolomic profiling separates
the two species but not the regions of cultivation. Lycium chinense and samples from
the semi-arid regions have significantly (p < 0.01) lower sugar contents and L. chinense
shows the highest antioxidant activity. Our results do not justify superiority of a specific
production area over other areas. Instead it will be essential to distinguish goji from
different regions based on the specific morphological and chemical traits with the aim to
understand what its intended uses are.
Keywords: Lycium, goji, metabolomics, HPTLC, 1H NMR, climatic region, chemometric
Abbreviations: ChP, Chinese Pharmacopoeia; EP, European Pharmacopoeia; HPTLC, High Performance Thin Layer
Chromatography; NMR, nuclear magnetic resonance; PCA, principal component analysis; SE, standard error.
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INTRODUCTION
In Chinese medicine, “daodi medicinal material” ( ,
dào dì yào cái) spells out the relationship between medicinal
material and one specific region with its traditional culture,
human behaviors, and environmental conditions. Generally
speaking, a daodi herbal medicine is derived from specific
germplasm, a specific geographic location, and cultivated and
processed with particular technologies with a long history. It is
commonly recognized to be of high, stable quality, and reliable
efficacy (based on traditional medicinal concepts), and has a
longstanding, good reputation (Guo, 2004; Xiao et al., 2009;
Zhao et al., 2012). However, nowadays the daodi concept is
often not accepted as sufficient for defining good quality and as
evidence for a species’ therapeutic benefits. The prevalence of
herbal medicines for health purposes, such as food supplements
and neutraceuticals, stimulates the botanical products market
(Dillard and German, 2000; Lachance and Das, 2007; Knöss and
Chinou, 2012; Hilton, 2016). For the widely consumed herbal
medicines, daodi areas cannot produce enough plant material
to meet the market demands; therefore, new cultivation areas
are developed. Therefore, studies on the authentication of a
species in the context of the production areas, quality criteria,
as well as standardized plantation and processing techniques
are increasingly important (Xiao et al., 2009). However, the
constitutions of herbal medicines are influenced by a wide range
of factors, such as meteorological conditions, environment and
processing method (Donno et al., 2012, 2016b; Zhang et al., 2012;
Qi et al., 2016; Shen et al., 2016). As a result, the authentication
and quality control of botanical products become even more
difficult.
This is the case for goji (Lycii frutus, fruits of Lycium barbarum
L. and L. chinense Mill.), which has been used as health food and
traditional medicine for millennia in China and other regions of
the world (Yao et al., 2018a). Recently, numerous phytochemical
and pharmacological studies focus on its health benefits, and
support its use as functional food (often sold under the marketing
concept of an alleged “superfood”) (Yao et al., 2011; Chang and
So, 2015; Qian et al., 2017).
While Ningxia is recognized as the daodi region of goji,
increasing market demands pushed the cultivation into new
regions in China and goji fields now stretch over different
geographical and climatic environments between 82◦E and
115◦E, 30◦N and 45◦N (Xu et al., 2014; Cao and Wu,
2015). These include temperate monsoon climate (Hebei),
temperate continental semi-arid climate (Ningxia, Gansu,
and Inner Mongolia), plateau continental climate (Qinghai),
and continental arid climate (Xinjiang). These different
environmental conditions influence both the appearance and
the metabolite profile of goji (e.g., amount of polysaccharides,
flavonoids, betaine, and carotenoids) (Zhang et al., 2012; Lin,
2013; Liu X.X. et al., 2015; Shen et al., 2016). Furthermore,
different species and cultivars are cultivated in different areas:
L. barbarum cultivars (e.g., Ningqi series) are widely cultivated
while L. chinense is only cultivated in Hebei (Cao and Wu, 2015).
In recent years, many of the new cultivation areas with different
climates have been officially labeled as “home of goji” ( ,
FIGURE 1 | Goji cultivation areas and “home of goji” in China. Up to 2015, the
total cultivation area was estimated to be 1500 km2, and nine cultivation areas
were labeled as “home of goji."
goˇu qıˇ zhı¯ xia¯ng) by different governmental bodies, a category
distinct from daodi (Figure 1). This label stands for standardized
production including growing it on large-scale fields and for high
quality products.
Thus, both “daodi” and “home of goji” stand for good quality
connected with a specific region. As these regions have different
climates, one must ask: How does goji differ among production
areas of distinct climatic regions?
Traditionally, good goji quality was defined as: Large berries
with red color, mild texture, few seeds, and sweet taste (Chinese
Pharmacopoeia Commission, 1963). Such morphological
characteristics are largely used by goji traders for sensory
identification. Recently, goji quality assessment also has relied
on a few marker compounds, such as polysaccharides and
betaine (Korea Food and Drug Administration, 2014; Chinese
Pharmacopoeia Commission, 2015a), and HPTLC flavonoid
fingerprint for species identification (European Directorate
for the Quality of Medicines and Healthcare, 2017). Since
berries from different species and cultivars are anatomically
and morphologically similar, molecular identification, infrared
spectroscopy, chemical fingerprint, and bioactivity are also used
for identification or evaluation (Zhang et al., 2001, 2016; Yao
et al., 2010; Xin et al., 2013; Donno et al., 2015).
In our study, we also include metabolomic profiling for quality
assessment, which has not been used for goji yet. Chemometric
approaches with chromatographic fingerprinting are known to
be effective metabolomic methods for quality control of herbal
medicine (Donno et al., 2016a; Guo et al., 2017; Liu et al., 2017;
Martinez-Frances et al., 2017). Bioactivity-based characteristics
are good quality indicators too, as they are pharmacologically
relevant (Walch et al., 2011; Liu et al., 2017). Since goji was
reported to have health protective effects against oxidative stress,
and was recommended as a natural antioxidant (Donno et al.,
2015; Benchennouf et al., 2017), we assume that antioxidant
effects are an adequate quality marker.
Our research questions / objectives and the resulting research
strategy are:
Does goji from climatically different production areas
show different quality characteristics? Can we correlate
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quality measurements with specific production areas? We
focus on the following quality measurements, which are
then correlated with the four main production areas:
fruit morphology, sugar and polysaccharide contents,
antioxidant activity, and metabolomic profiling.
At least two species are traded widely as goji, requiring an
understanding of the species similarities and differences.
For this comparative characterisation and identification we
use HPTLC.
To understand the spread of goji production in China over
time we use historical records.
MATERIALS AND METHODS
Historical Literature Study
Information about historic goji cultivation areas was retrieved
from the 32 ancient Chinese herbals used in our previous study
(Yao et al., 2018a); and the toponymes were cross-linked to
contemporary maps. For developments in recent decades, the
search engine Baidu1 was employed, using “ ” (“home
of Chinese goji,” zho¯ng guó goˇu qıˇ zhı¯ xia¯ng) as keyword;
Then, the source information was tracked down. All data were
integrated and maps were generated with R 3.4.1 and the R
package REmap (Liang, 2015; R Core Team, 2017).
Plant Material
Fieldwork was carried out by the first author for several weeks
between August 2014 and September 2016 and goji samples
were collected in the main production areas in China: Ningxia,
Qinghai, Xinjiang, and Hebei. In total 51 fruit samples of
L. barbarum and L. chinense were collected directly from
the farmers, or were offered by institutions (Ningxia Qixiang
Biological Foodstuff Co., Ltd., Hebei Julu Shengying Gouqi
Co., Ltd., Xinjiang Gouqi Development and Management
Center of Jinghe County, Jinghe Guokang Gouqi Specialized
Farmers Cooperatives), or were bought in the Zhongning Goji
Distribution Center, Julu Goji Yinhua Market, Xinjiang Jinghe
Goji Market, Chengdu Hehuachi Chinese Herbal Medicine
Market, and An’guo Chinese Herbal Medicine Market. This
includes L. chinense: ten samples from the monsoon region;
and L. barbarum: 25 from the semi-arid region, nine from the
plateau region, and seven from the arid region. An authenticated
reference standard sample of L. barbarum fruits was bought
from the National Institute of Food and Drug Control of China,
batch No. 121072-201410. Fruits with voucher specimens were
collected in Zhongning County of Ningxia, Julu County of Hebei,
and the National Gouqi Germplasm Garden in Yinchuan City of
Ningxia. Totally, 24 specimens are deposited in the herbarium of
the University of Zürich and ETH Zürich (Z+ZT).
Morphological Identification
Identification of the specimens is based on the Flora of China
(Wu et al., 1994) and Lycium specimens from the China National
Herbarium (PE): The barcode No. of the referred specimens are
1http://www.baidu.com
01882829, 00633675, 00633726, 00031413, 00031311, 00031382,
01432314, 00031381. Fruits of the following two specimens were
used as reference for HPTLC fingerprint analysis: Z.000106520
(L. chinense Miller) and Z. 000106530 (L. barbarum L.).
Chemicals and Reagents
Methanol (HPLC Ultra) was purchased from Roth; Ethyl acetate
(98%+), Formic acid (99.5%), Glacial acetic acid (99.5%)
were bought from Acros Organics; Dichloromethane (DCM)
(99.9%+), Dimethylsulfoxide-d6 (DMSO-d6), 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS), and Trifluoroacetic acid (TFA)
(99%) were obtained from Sigma; all reagents and chemicals
are of analytical grade. NP reagent: 1 g Diphenylborinic acid
aminoethylester in 200 ml Ethyl acetate. PEG reagent: 10 g
Polyethyleneglycol-400 in 200 ml Dichloromethane.
Morphological Measurements
Fruits were placed in a drying oven at 60◦C for 6 h then were
cooled down overnight. High-resolution images of the fruits were
obtained by using an image scanner (Epson Perfection V750 Pro,
United States). Length and width of each fruit were measured
in Adobe Photoshop by using the ruler tool, which was done
by selecting a smallest rectangle to cover the fruit outline and
recording the length and width of the corresponding rectangle.
Color parameters of the fruit images were represented by RGB
values which were measured as follows: A smooth and clean
area on the fruit image was selected such that its color was
representative of the whole fruit; then, the RGB value of this area
was read from the information toolbox using the color sampler
tool in Photoshop.
For weight measurement 50 fruits per sample were randomly
selected and weighed. This was repeated three times per sample.
If the difference between any two of the three measurements
was over 5.0%, another batch of 50 fruits was weighed. The
process was repeated until there were three measurements with
differences below 5.0%.
Data were analyzed with R 3.4.1 in RStudio 1.0.153. R packages
of ggplot2, multcomp, and MASS were used (Venables and
Ripley, 2002; Hothorn et al., 2008; Wickham, 2009; R Core Team,
2017).
HPTLC Fingerprint Analysis
HPTLC fingerprint analysis was applied on all samples based on
the monograph of Lycii fructus (04/2015:2612) in the European
Pharmacopoeia 9.0 (European Directorate for the Quality of
Medicines and Healthcare, 2017), with slight modification.
Test solution was prepared as follows: To 0.10 g of powdered
goji, 7 ml of water were added and sonicated for 10 min at room
temperature. After centrifugation (5000 r/min for 5 min), 4 ml of
the supernatant was loaded onto a 6 ml solid phase extract (SPE)
C18 cartridge (Strata C18-E, Phenomenex, United States) that
had been pre-treated first with 3 ml of methanol, dried, and then
with 3 ml of water (not dried). The loaded and dried cartridge was
twice washed with 1 ml of water-methanol (90:10) and dried. The
test solution was obtained by elution of the cartridge with 1 ml of
methanol. During loading, clean-up and elution the flow rate of
the solvent should not exceed 120 drops per minute.
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A CAMAG HPTLC system (Muttenz, Switzerland) was
employed, with an automatic TLC sampler 4 (AST 4) for
application, an automatic developing chamber 2 (ADC 2)
for developing, a chromatogram immersion device III for
derivatization, a TLC plate heater III, a TLC visualizer 2 for
imaging and a software visionCATS 2.0 for data analysis. Strata
C18-E (55 µm, 70 A, 500 mg/6 ml) solid phase extraction
cartridges from phenomenex were used for sample preparation,
and the plates used were HPTLC glass 20 cm × 10 cm, Si 60 F254
(Merck, United States).
Application parameters were: Spray gas = air; Sample
solvent type = methanol; filling speed = 15 µl/s; predosage
volume = 200 nl; retraction volume = 200 nl; rinsing
cycles/vacuum = 1/4 s; filling cycles/vacuum = 1/0 s; rinsing
solvent name = methanol; nozzle temperature = unheated; rack
in use = standard. And 10 µL of test solution and 2 µl of
reference solution were applied as bands of 8.0 mm, while the
application position was 8.0 mm from the lower edge of the plate;
first position X: 20.0 mm, distance: 11.4 mm.
Developing conditions were: Humidity control: 33% with
MgCl2; saturation: 20 min with filter paper; developing distance
from application position/lower edge: 62/70 mm; developing
solvent: Ethyl acetate, water, acetic acid, formic acid 100:27:11:11;
developing time: 20 min; plate drying: 5 min.
Derivatization was done with chromatogram immersion
device III at speed of 5 with time of 0 s. Derivatization reagents:
NP regent and PEG regent. The developed plate was preheated at
100◦C for 3 min; the warm plate was treated with NP reagent, and
photographed when dry; treatment with PEG reagent followed,
and pictures were taken after 5 min. Images were taken at
conditions of “auto capture, Auto, level 85%, Band.” The images
were analyzed with visionCATS 2.0.
1H NMR Profiling
For the metabolomic profiling of all samples, the method of
Booker et al. (2016) was modified: 0.0500 g of goji (fine powder,
freeze dried) in a 1.5 ml centrifuge tube with 0.900 ml DMSO-
d6 and 0.100 ml of 0.100 g/ml DSS solution. After vortexing
(Rodamixer, United Kingdom) for 30 s, the samples were
sonicated in an ultrasound bath (XB22, Fisher, United Kingdom)
for 20 min. Then, the solution was centrifuged for 5 min at
14,000 rpm (EBA 21, Hettich, Germany). Supernatant (0.600 ml)
was transferred into a 5 mm diameter NMR spectroscopy tube for
1H NMR analysis (AV 500, Bruker BioSpin GmbH, Germany).
The parameters were: solvent = DMSO, temperature = 300,
experiment = 1D, number of scans = 128, pulse width = 13.9,
acquisition time = 3.172, spectrometer frequency = 500.13,
nucleus= 1H.
Since the samples could not be analyzed in one group, they
were separated into five batches. To ensure the stability of the
measurement, in every batch we took one sample for triplicated
extraction and testing; one of the samples was analyzed in each
batch.
The data were processed by MestReNova 9.0 (Mestrelab
Research S.L., Spain). After phase correction and baseline
correction, we calibrated the chemical shift reference by adjusting
the first right DSS peak at 0.000 ppm. The spectrum was
FIGURE 2 | Goji cultivation map according to Chinese historical herbals
(100 CE - 700 CE). The map was produced based on the historical maps of
the Han and Tang Dynasty. Data are from Shennong’s herbal (ca. 100 CE),
Mingyi Bielu (ca. 500 CE), and Qianjin Yifang (682 CE). Later, good quality goji
was consistently ascribed to the semi-arid region.
FIGURE 3 | Development of goji cultivation since 1960s. Cultivars of
L. barbarum were introduced in large scale from Ningxia (dark blue) to Inner
Mongolia, Xinjiang, Qinghai (bright blue); and in lesser degree into Tibet,
Hubei, and Hebei (white) (red arrows). The green arrow shows the expansion
route of L. chinense westward within Hebei.
normalized by setting the total area of peaks (δ = 10.00–
0.000 ppm) to 100.000. The binning function was applied to
integrate the peak area by small buckets (0.040 ppm) with the
method of “sum.” The data were exported as a “.csv” file and
analyzed with R and R package ggplot2 (Wickham, 2009; R Core
Team, 2017).
Contents of Hydrolyzed Sugars and
Polysaccharides
Moisture of all samples was measured according to the
method No. 0831 of the Chinese Pharmacopoeia (Chinese
Pharmacopoeia Commission, 2015b). 20 g of fruits were placed in
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an open aluminum box (with cover) into a drying oven at 105◦C.
After 4 h, the box was weighed every half hour until the weight
no longer decreased, then all the dried samples were weighed and
the moisture content calculated.
Hydrolyzed sugars were extracted according to the
monograph of Xanthan Gum (04/2009: 1277) of the European
Pharmacopoeia 9.0 (European Directorate for the Quality of
Medicines, and Healthcare, 2017). To 0.050 g of goji powder in a
thick-walled centrifuge tube, 2.0 ml of a 230.0 g/L solution of TFA
was added, and shacked vigorously. The test tube was closed and
heated at 120◦C for 1 h. The hydrolysate was centrifuged, and
1.0 ml of the clear supernatant liquid transferred into a 10.0 ml
flask, and 5.0 ml of water was added to obtain the test solution.
Polysaccharides were extracted according to the monograph
of Lycii fructus in the Chinese Pharmacopoeia (Chinese
Pharmacopoeia Commission, 2010; Chinese Pharmacopoeia
Commission, 2015a).
The contents of hydrolyzed sugars and polysaccharides were
measured with the phenol-sulphuric acid method (Zou et al.,
2011): glucose was used to plot a standard curve, and the final
result was corrected with the moisture of the samples.
Antioxidant Activity
Fifteen samples (three from monsoon, eight from semi-arid, two
from plateau, and two from arid) were randomly selected, and
each of them was prepared as follows: Fifty grams of fruits were
extracted with 1000 ml of 95% ethanol, followed by 50% ethanol,
and hot water. The supernatants were collected separately and
concentrated with a rotary evaporator before frozen and dried in
a freeze dryer (Zou et al., 2014). The extracts were named as A-
95% EtOH, B-50% EtOH, and C-H2O, separately. Another 50.0 g
of goji was extracted with 1000 ml of boiling water for the aqueous
extract (Zou et al., 2014), and processed as above, and the extract
was named as D-H2O.
The antioxidant activities of the extracts were tested using a
modified ABTS method (Li et al., 2012). The obtained extracts
were solved in 95% EtOH in the ratio: 1000.0, 800.0, 600.0, 400.0,
and 200.0 µg/ml. Quercetin was used as positive control. IC50
values, the concentration of 50% radical-scavenging effect, were
calculated by linear regression. Data were analyzed with R and
package multcomp (Hothorn et al., 2008; R Core Team, 2017).
RESULTS AND DISCUSSION
Ancient and Current Goji Distribution in
China
The ancient distribution of goji cultivation areas is shown in
Figure 2. The earliest goji record was found in the Shennong’s
Herbal Classic describing that around 100 CE it grew in
Changshan (now Hebei) during the Han Dynasty (Shang,
2008). According to the ascribed bitter taste we assume that
they were describing L. chinense. Around 500 CE, goji was
recorded to appear widely around Tangyi at south of Hebei
(Su, 1981; Tao, 1986). Sun Simiao recorded 682 CE that goji
grew in the semi-arid climatic region in Ganzhou, Yecheng,
Lanzhou, Jiuyuan, and Lingzhou; he also described its cultivation
technology and the sweet taste and superior quality of the
berries compared to other regions (Sun, 1997). Very probably
he referred to L. barbarum. From the Song Dynasty (10th-
13th century) onward, goji was mentioned widely, and most
records agreed that goji (probably L. barbarum) from semi-
arid regions had the best quality (Wu, 1959; Tang, 1982; Li,
2003). Overall, goji cultivation seems to have begun in the
East (Changshan) and later shifted westward to the semi-arid
regions.
Since the 1960s, goji was introduced further west and north
to the Inner Mongolia (semi-arid region), Qinghai (plateau
region), and Xinjiang (arid region); in Hebei, cultivation shifted
westward from Jinghai to Julu and Qinglong County (Figure 3),
while L. barbarum was also introduced for cultivation (Cao
and Wu, 2015). Since the Chinese pharmacopoeia exclusively
accepts L. barbarum as medicinal goji (Chinese Pharmacopoeia
Commission, 2015a), L. chinense is only locally cultivated. The
fruits of L. chinense are sparsely consumed in China, but in
Japan and Korea, the two species are used interchangeably (Korea
Food and Drug Administration, 2014; Japanese Pharmacopoeia
Editorial Committee, 2016).
In 1961, Zhongning County of Ningxia was assigned to be the
unique national plantation for goji by the State Council of the P.
R. China (Su, 2002). At a small scale, goji was also introduced to
Hubei and Tibet in the 1970s and 2000s, respectively (Cao and
Wu, 2015).
In recent years, the increase of goji consumption stimulated a
drastic increase of goji cultivation and the total cultivation area in
China now exceeds 1500 km2. As shown in Table 1, up to 2017,
eight “home of Chinese goji” labels and one “home of Hebei goji”
were attributed to cultivation areas in different climatic regions.
The latter is probably due to the long cultivation history of the
area and not to the size of production area which covers only
around 4 km2. Both titles indicate the reputation of high quality
products.
HPTLC Fingerprint for Species
Identification
Fruits of L. barbarum and L. chinense cannot be distinguished
readily (Xin et al., 2013). We therefore checked and confirmed
the identity of all samples with HPTLC fingerprinting (Figure 4).
Flavonoids fingerprints of the same species are highly similar,
indicating their chemical similarity, while fingerprints of the two
species differ. The most obvious differences are: L. barbarum
shows a yellow zone at Rf = 0.32 ∼ 0.35, which is rutin; while
L. chinense lacks rutin, but has a yellow zone at Rf= 0.25∼ 0.27,
which might be a derivative of rutin.
Morphological Characteristics
Length, width, length/width ratio, and redness are intuitive
criteria used by stakeholders (cultivators, middlemen, and
manufacturers) to evaluate goji quality. Figure 5A shows an
image of goji. Samples from the semi-arid region cannot be
separated morphologically from the other regions and were
excluded for further analysis (Figures 5G,H). According to a
quadratic discriminant analysis (QDA), the within training data
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TABLE 1 | An overview of “home of goji” in China until 2017∗.
Climatic region Province Cultivation location Issued tittle Issue department Issue time
Monsoon Hebei Julu Home of Hebei goji HBG 2002
Semi-arid Ningxia Ningxia Home of Chinese goji SC 1995
Zhongning EFA 2000
Inner Hangjinhou Qi SFA 2004
Mongolia Wulateqian Qi EFA 2013
Plateau Qinghai Nuomuhong Farm EFA 2015
Arid Xinjiang Jinghe MA 1998
Nongwu Shi SFA 2001
Jinghe SFA 2004
∗Semi-arid, temperate continental semi-arid climate; Arid, continental arid climate; Plateau, plateau continental climate; Monsoon, temperate monsoon climate. SC, the
State Council of the P. R. China; MA, Ministry of Agriculture of P.R. China; SFA, State Forestry Administration of P.R. China; EFA, Economic Forest Association of China;
HBG, Government of Hebei Province. (Cao and Wu, 2015; State Forestry Administration of P.R. China, 2017).
FIGURE 4 | Goji flavonoid fingerprint by HPTLC. (A) References (L1, Rutin Rf = 0.34 and Scopletin Rf = 0.88; L2, Lycii fructus standard reference; L3, voucher
specimen of L. barbarum; L4, voucher specimen of L. chinense); (B) Samples (R1, Rutin and Scopletin; R2 – R13, samples of L. barbarum; R14 – R15, samples of
L. chinense). Derivatization was done with NP regent and PEG regent, and images were taken at 366 nm.
classification error rate is 12.8%. Samples from monsoon, plateau
and arid regions differ in their morphology (Figure 5G).
Overall, L. chinense fruit samples from Hebei are significantly
lighter, smaller and brighter in color (Figures 5B–D,F), while the
heaviest and largest fruits stem from the plateau (Figures 5C,D).
In the plateau and arid region, the drastic temperature fluctuation
between day and night seem to have a positive influence on fruit
weight (Qi et al., 2016).
Commercial goji are normally categorized into six grades
depending on the number of fruits per 50 g. The best grade
contains 180–200 fruits per 50 g, and the lowest grade 980 fruits.
Figure 5B shows a weight comparison of goji from different
climatic regions.
The shape of goji fruits, which is measured by length/width
ratio, differs significantly (p < 0.01) among regions (Figure 5E).
Goji from the plateau region has the largest, while the arid region
shows the smallest ratio. Goji from the plateau appears to be
elongated oval or lanceolate, while samples from other regions are
of shorter oval shape. This character is often used by stakeholders
to identify the origin of goji. In the market, goji with larger berries
tend to get higher prices. Therefore, farmers of the plateau region
often press goji before selling it.
Redness is attractive for most consumers, unless it is too bright
which may hint at sulfur treatment. In the monsoon region it
is generally difficult to dry goji in the sun, and therefore sulfur
fumigation is often applied to avoid degradation due to moisture.
As a result, Hebei goji tends to be bright red in color. In the
arid region sulfur is rarely used and goji redness is lower. The
use of sulfur in semi-arid and plateau regions depends on the
weather, whereas sulfur is applied in case of rain or lack of sun. In
recent years, artificial drying rooms have been used increasingly
to decrease the use of sulfur.
Fruit traits of goji are affected by temperature, humidity,
duration of sunshine and altitude (Lin, 2013; Qi et al., 2016).
However, fruit morphology may differ even within the same
climatic region (Lei et al., 2013). Moreover, the drying process
has an impact on the color (Ma et al., 2008). Goji from
the semi-arid region, especially Ningxia, is recognized as
having higher quality compared to other regions. However,
from our morphological analysis goji berries from the semi-
arid region are not distinguishable from berries from other
regions and, therefore, it is possible to wrongly label goji
from different regions as “Ningxia goji” to charge high
prices.
1H NMR Based Metabolomic Profiling
With the metabolomic profiling we were able to separate the two
species but not the samples from different cultivation regions
(Figure 6). Differentiation of several other species according to
their metabolomic profiles has been done before, e.g., Rhodiola
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FIGURE 5 | Comparison of morphological traits of goji from different climatic regions. (A) Example of measuring shape and color; (B) Average weight per 50 fruits;
(C) Average fruit length; (D) Average fruit width; (E) Average length/width ratio of fruits; (F) Average redness of fruits; (G) Morphological PCA score plot without
semi-arid region; (H) Morphological PCA score plot of all regions.
spp. and Curcuma spp. can be separated successfully (Booker
et al., 2014, 2016).
The typical spectra of goji from different climatic regions are
shown in Figure 6A. Profile No.2 differs from the others in
peak shape, especially between 2.50 and 5.00 ppm. PCA analysis
with data from 0.00 to 10.00 ppm shows that the two species
L. barbarum and L. chinense are separated by their metabolomics
(Figure 6B). The region between 3.00 and 6.00 ppm, which
importantly includes the signals from diverse sugars, turned
out to differ strongly between the two species, which again
becomes visible with PCA (Figure 6C); therefore, this part is a
characteristic region for species identification.
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FIGURE 6 | 1H NMR spectra and PCA projections of the first two principle components. (A) Spectra of goji samples from different climatic regions (δ = 10.00 –
0.00); (B) Score plot based on δ = 10.00 – 0.00; (C) Score plot based on δ = 6.00 – 3.00.
Similar results were reported with a chemometric approach
based on Fourier-transform infrared spectroscopy (FT-IR),
by which goji from Hebei was discriminated from that
of other regions, while others were clustered closely (Shen
et al., 2016). HPLC was successfully used to differentiate
between genotypes of hybrid cultivars between L. barbarum
and L. chinense, as well as fruit samples of the same
genotype but dried in different methods (Donno et al.,
2016b). Furthermore, chemometric approach was applied
to FT-IR, high performance size-exclusion chromatography
(HPSEC), and pre-column derivatization high-performance
liquid chromatography (PCD-HPLC), which indicated that
polysaccharides of goji from different regions barely differed
(Liu W. et al., 2015). These findings are supported by a
recent research which shows that the molecular structure of
polysaccharides from goji (L. barbarum only) of different regions
is highly similar (Wu et al., 2015). This similarity is also
shown by our metabolomic analysis, where L. barbarum samples
from different cultivation areas cluster together, but differ from
L. chinense.
Hydrolyzed Sugar and Polysaccharides
Lycium chinense as well as samples from the semi-arid regions
have significantly (p < 0.01) lower sugar contents compared
to the plateau and arid region (Figure 7A). No differences
in polysaccharide content could be found neither between the
species nor the cultivation regions (Figure 7B).
Goji contains sugars at a relatively high level, and goji
polysaccharides are recognized as main bioactive compounds
(Xie et al., 2016; Yao et al., 2018b); as a result, sweetness and
contents of polysaccharides are quality criteria of goji. The
accumulation of sugar and polysaccharides in goji was reported to
be affected by temperature, humidity, and altitude; variation even
in the same climatic region is huge (Lei et al., 2013; Qi et al., 2016).
Therefore, the differences among climatic regions are relatively
small.
Analysis of the Antioxidant Activity
While all the IC50 values are far higher than that of the positive
control, we find differences among goji from different regions.
Lycium chinense from the monsoon region shows the highest
antioxidant activity for all preparations, while goji from the
plateau shows for most preparations the lowest antioxidant
activity, although differences are non-significant (p > 0.05)
(Table 2). Thus, L. chinense seems to be more potent as a natural
antioxidant.
As traditional food supplement, goji has been used as
medicinal liquor, i.e., soaked in spirit (40–70% EtOH),
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FIGURE 7 | Comparison of sugar content in goji from different climatic
regions. (A) Average contents of hydrolyzed sugar; (B) Average contents of
polysaccharides.
as condiment boiled with food, or as tea infused with
boiling water. Our extracts imitate these traditional uses
(Table 3).
FIGURE 8 | Morphological, chemical, and antioxidant characteristics of goji
from different climatic regions. Values are calculated by the ratio relative to the
maxims.
The highest antioxidant activity was found for the 50%
EtOH extract which imitates medicinal liquor, followed by water
extracts. The 95% EtOH extract shows the lowest activity.
Our results therefore suggest that traditional goji wine acts as
an antioxidant drink, as does goji tea, and do support the
recommendation of goji as a natural antioxidant (Donno et al.,
2015; Benchennouf et al., 2017).
Overall Comparison of the Different
Regions and Species
Figure 8 summarizes the above morphological, chemical, and
antioxidant data and provides a visual overview of similarities
and differences. Overall, L. chinense from the monsoon region
TABLE 2 | IC50 value (µg/ml) for scavenging ABTS·+ compared by regions∗.
Climate A-95% EtOH B-50% EtOH C-H2O D-H2O
Arid 90.95 ± 2.45 ab 66.00 ± 3.30 ab 76.60 ± 3.10 b 70.65 ± 6.40 ab
Monsoon 77.90 ± 3.27 a 37.50 ± 0.16 a 39.30 ± 0.49 a 44.10 ± 1.80 a
Plateau 108.30 ± 5.40 ab 72.50 ± 3.70 b 92.55 ± 3.55 b 71.85 ± 7.75 ab
Semi-arid 105.74 ± 14.91 b 56.41 ± 13.42 ab 84.59 ± 13.09 b 74.51 ± 14.73 b
∗The IC50 value of quercetin (positive control) was 0.75 ± 0.01 µg/ml (mean ± SE). Multiple comparison was carried out with the method of “Tukey”; and in the same
column, means sharing the same letters are not significantly different from each other (p > 0.05).
TABLE 3 | IC50 value (µg/ ml) for scavenging ABTS·+ compared by preparations∗.
Preparations Monsoon Semi-arid Plateau Arid
A-95% EtOH 77.90 ± 3.27 c 105.74 ± 14.91 c 108.30 ± 5.40 b 90.95 ± 2.45 b
B-50% EtOH 37.50 ± 0.16 a 56.41 ± 13.42 a 72.50 ± 3.70 a 66.00 ± 3.30 a
C-H2O 39.30 ± 0.49 ab 84.59 ± 13.09 b 92.55 ± 3.55 ab 76.60 ± 3.10 ab
D-H2O 44.10 ± 1.80 b 74.51 ± 14.73 ab 71.85 ± 7.75 a 70.65 ± 6.40 ab
∗The IC50 value of quercetin (positive control) was 0.75 ± 0.01 µg/ml (mean ± SE). Multiple comparison was carried out with the method of “Tukey”; and in the same
column, means sharing the same letters are not significantly different from each other (p > 0.05).
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(blue) differs most while the other regions are more similar,
differing among few sensory characteristics only, such as length,
weight and sugar contents.
CONCLUSION
Ningxia, with a semi-arid climate, always had the reputation
of producing best goji quality (a so-called daodi production
area). But today, new cultivation areas in different climatic
regions are recognized as sources of good goji quality too.
Depending on the criteria we look at, we find different patterns
for goji quality in relation to area of production: Since the
Tang Dynasty, goji from semi-arid regions was recognized
for its superior quality; however, based on morphological and
metabolomic characteristics as well as antioxidative activity it is
not possible to separate semi-arid goji from samples from other
regions.
Our results do not justify superiority of a specific production
area over other areas. Rather, they suggest using goji from
different regions for different purposes, based on the specific
morphological and chemical traits. For example, large fruits
from the plateau are suitable to be marketed as fresh fruits;
goji with high sugar content is useful for conserved food; and
high antioxidative activity combined with bitterness may suggest
medicinal use.
The metabolomic approach combined with morphological
analysis and bioactivity evaluation allows for capturing these
different goji quality clusters, but, at the same time allows
detecting outliers such as different species. This would not be
possible with exclusive chemical analysis.
Fruits of L. barbarum and L. chinense differ in their metabolite
profiles including HPTLC flavonoid fingerprint and 1H NMR
based chemometric analysis, as well as their antioxidant activity.
As these two species are used interchangeably as medicinal goji,
we suggest treating them as two separate botanical drugs. In case
of food use, high sugar content and large fruit size are important,
which supports the wider use of L. barbarum for food.
Future research on the bioactivity of the two species as
well as samples from different cultivation areas beyond China
will provide necessary data for specific and most appropriate
uses.
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Quality control of goji (fruits of Lycium spp.): A value chain 
analysis perspective 
ABSTRACT 
Ethnopharmacological relevance: Goji (fruits of Lycium spp.), which has been used as 
traditional food and medicine for thousands of years in Asian countries, is 
increasingly consumed globally as an herbal medicine. Quality of herbal medicines is 
critical for safe use and has been shown to be affected by value chains. 
Aim of the study: Using a value chain (VC) framework, we aim at understanding the 
influence of different VC types on goji quality and revenue of stakeholders. 
Materials and Methods: Participant observation and semi-structured interviews were 
conducted during five months of fieldwork in the main production areas in China with 
a total of 65 stakeholders. Quality of goji, behaviour and financial performance of 
stakeholders was documented and analysed for different VCs.  
Results: Ten different types of VCs were identified. VCs with vertical integration and 
horizontal collaboration were found to have a more coherent quality control and better 
goji quality as well as improved stakeholders’ financial performance. Vertical 
integration at different levels was found for independent farmer-based VCs, horizontal 
collaboration was found in the cooperative-based VCs. Full vertically integrated VCs 
were found in large-scale production.  
Conclusions: Goji quality and stakeholders’ revenues are linked with different types 
of VCs which mirror stakeholders’ behaviour driven by target markets. Considering 
their positive influence on quality and revenues, well-developed vertically integrated 
value chains are likely to become more important in the near future.  
Keywords: Lycium, goji, value chain, financial performance, stakeholders, 
quality control, traceability, herbal medicine product 
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1. Introduction
Humans rely on plants for food and medicine (Ekor, 2014; Gu and Pei, 2017;
Heinrich, 2010; Knoss and Chinou, 2012; Leonti and Casu, 2013; Liu and Cheng, 
2012; Qu et al., 2014). In the wake of globalization, traditional and local plant-derived 
foods are frequently turned into commodities such as food supplements or 
nutraceuticals. It is estimated that this is a market of over $ 150 billion with an annual 
increase rate of more than ten percent (Dillard and German, 2000; Hilton, 2017; 
Jennings et al., 2015; Shikov et al., 2017). Overall, traditional plant-derived foods and 
medicines are of increasing importance both, for health problems in people’s daily 
lives and within the context of fast developing business networks and opportunities. 
However, the larger the market becomes the more quality problems arise (Posadzki et 
al., 2013). Most herbal medicinal products are applied in the form of mixtures which 
consist of hundreds of compounds, which makes quality control notoriously difficult 
(ChP Commission, 2015; BP Commision, 2017; EDQMH, 2017). 
Moreover, in many countries the regulations of such classic formulas continue to be 
loose (Cyranoski, 2017; Qiu, 2007). Regulations for botanical food supplements are 
generally less strict and good quality is even more of an issue (Shao, 2017). Quality 
control of plant-derived products is crucial for their safety and effectiveness. However, 
are the present methods sufficient and what needs to be understood about the 
processes from the initial agricultural production / collection to the final commercial 
products? 
Many quality control methods have been developed for the authenticity, purity, and 
the analysis of active substances of botanical products. They mainly rely on 
morphology, phytochemical analysis, and molecular identification. The most common 
methods are chromatography-based quantitative and qualitative analysis of 
constituents. These include high performance liquid chromatography (HPLC), thin 
layer chromatography (TLC) or high performance thin layer chromatography 
(HPTLC), infrared spectrometry (IR), gas chromatography (GC) and capillary 
electrophoresis (CE). Mass spectrometry (MS) is often used to identify substances and 
56
chemometrics is applied to analyse relationships among samples (Donno et al., 2016; 
Guo et al., 2017; Kokotkiewicz et al., 2017; Liang et al., 2004; Maldini et al., 2016; 
Martinez-Frances et al., 2017; Reich et al., 2006; Wagner et al., 2011). Molecular 
identification, including DNA barcoding and DNA metabarcoding, are seen as 
important tools for species authentication (Chen et al., 2010; Heinrich and 
Anagnostou, 2017; Jia et al., 2017; Raclariu et al., 2017; Xin et al., 2013; Zhang et al., 
2001). Bioactivities are also measured and often applied together with metabolomic 
analyses (Donno et al., 2015; Liu et al., 2017; Walch et al., 2011). Considering the 
complexity of botanical products, profiles of active substances provide only limited 
chemical information with metabolomic approaches being better suited to depict this 
complexity. They were successfully used in quality control of botanical products such 
as coffee, camellia oil, goji, or Rhodiola species (Booker et al., 2016; de Moura 
Ribeiro et al., 2017; Heinrich, 2008; Kim et al., 2010; Pelkonen et al., 2012; Shi et al., 
2018; Yao et al., 2018). 
Safety is an important attribute of good quality. While safety issues may arise due 
to inherent toxic constituents of a plant, they usually are due to external contamination 
through, e.g., heavy metals, pesticides, microbes, mycotoxins, and sulphites. 
Fortunately, all these substances are detectable with suitable technologies (Fu et al., 
2017; Kan et al., 2011; Posadzki et al., 2013; Rather et al., 2017; Sharma et al., 2017; 
Silins et al., 2014; Yang et al., 2018; Yang et al., 2017; Yu et al., 2017; Zhang et al., 
2012). Accordingly, the current technologies allow for the evaluation of the 
metabolomic and biological properties, as well as the harmful ingredients of a 
botanical product. However, are these sufficient for ensuring the quality and safety of 
botanical products? 
The concept of value chains, which provides a framework for describing links 
between producers and consumers focusing most notably on the socioeconomic 
benefits to producers (Booker et al., 2012) has in recent years been expanded to also 
include a basis for understanding the products’ composition and thus their potential 
therapeutic benefits. Heinrich (2015) and Raclariu et al. (2017) mapped different 
quality control methods along production stages (source, manufacture, and retail), 
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indicating that quality control is dynamic and may consist of various inspections 
along the supply chain of herbal products. Such measures were also applied onto 
functional foods, neutraceuticals, spices and herbs (Sarkisyan et al., 2017; Shao, 2017; 
Székács et al., 2018). Obviously, an effective quality control of a botanical product 
consists of a systematic control of the whole supply chain or value chain.  
Value chain analysis has originally been used to expound the value-adding 
activities of an organization, including the primary activities and support activities 
(Porter, 2008; Porter, 2001). The term supply chain has been used for all movements 
from the raw material to the final product across different parties, and thus comprises 
exhaustive flows of materials, funds, and information (Mentzer et al., 2001). 
Commonly, the two terms are used synonymously and value chain refers to the life 
cycle of a product, from raw materials to final products (Ayers, 2010; Booker et al., 
2012; Heinrich, 2015). A botanical product always transits several levels of 
stakeholders and organizations from cultivation to processing and distribution, before 
it reaches the final consumers (Székács et al., 2018).  
Fig. 1. Model of value chains and flow of materials in a value chain.  a SH, 
stakeholder; adapted from Lambert et al. (1998); Raclariu et al. (2017); Székács et al. 
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(2018). 
Value chains of the same product can be diverse. As is shown in Fig. 1, a value 
chain may include different stakeholders, who contribute at different supply stages. It 
has been argued that vertically integrated value chain (VIVC) generally result in a 
better quality of products and can also enable a fair compensation of producers (Aung 
and Chang, 2014; Booker 2016; Datta, 2017). In a supply chain, three main flows are 
distinguished: 1) information flow is bidirectional among stakeholders; 2) primary 
product flow is unidirectional from primary producer to consumer; and 3) primary 
fund flow is unidirectional from consumer to primary producer. These flows interact 
and influence each other as has been shown in many case studies (Booker et al., 2016; 
Howieson et al., 2016; Székács et al., 2018). In the case of turmeric, for example, the 
producers’ livelihoods were found to vary among value chains. Integrated value 
chains were found to result in higher quality products, which were shown to have an 
impact on chemical variability and quality of the product (Booker et al., 2014; Booker 
et al., 2016). To understand the influence of different value chains of botanical 
products on both, the quality of the product and the income of the stakeholders, the 
three flows (product, information, and money) and their interrelatedness need to be 
analysed and understood. 
In this study we analyse value chains of goji and their influence on stakeholders’ 
financial performance as well as on the quality and safety of goji. In Asian countries 
the dried fruits of Lycium spp., namely goji or wolfberry, is a traditional medicine and 
food, and has become increasingly popular as a healthy food globally (Qian et al., 
2017; Yao et al., 2018). China is the main production country and yields ca. 25 to 30 
tons of dried goji annually (Cao and Wu, 2015; Xu, 2014). However, goji products are 
often of concern due to serious quality problems. For example, according to the US 
import alerts and EU RASFF notifications from 2009 to 2017, 208 batches of goji 
products were contaminated with pesticides or sulphur, of which some were even 
labelled as organic (FDA, 2017; RASFF, 2017). During our fieldwork in Chinese 
production areas in different climatic regions, we found diverse value chains 
interrelated to varying degrees with poor quality of goji, unfair sharing of revenues, 
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and poor livelihoods of primary producers. Therefore the objectives of this research 
are:  
What value chains exist for goji products? What information can be gained from a 
value chain analysis with regards to both best practices in supplying high quality 
materials and for identifying problems along the diverse value chains? What revenues 
gain the stakeholders in different value chains? How do finances and quality control 
interrelate?  What are effective approaches for quality control and a fair sharing of 
revenues? 
2. Materials and methods
2.1. Fieldwork 
Goji harvesting time stretches from June to October. Fieldwork was done during 
five months of harvesting periods 2014, 2015 and 2016 in Zhongning County of 
Ningxia, Ge’ermu City of Qinghai, Jinghe County of Xinjiang, and Julu County of 
Hebei, which are the main goji production areas and trading centres in China (Fig. 2). 
Participant observation and semi-structured interviews were conducted with 
experienced participants of the goji industry: 24 farmers, 7 harvesters, 5 village 
leaders, 5 processing firm leaders, 14 retailers, 8 middlemen, directors of two official 
goji management institutions (Goji Management Bureau of Jinghe in Xinjiang and the 
Ningxia Goji Institute). Farmers, harvesters, village leaders, and retailers were 
selected randomly in the core cultivation areas or trading centre of the regions visited; 
middlemen were visited as follows: the first middleman was introduced by our 
counterpart in Ningxia, and the others were introduced by the first middleman; the 
interviewed institutions were introduced by our counterpart in Ningxia. 
Questionnaires for different participants are shown in S2; in addition, we encouraged 
the interviewees to provide any information as they wanted. Interviews were recorded 
with a voice recorder and stored in the first author’s home. Moreover, two authors 
attended a national goji industrial summit which was held in Ningxia on 20th August, 
2015. 
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Fig. 2 Fieldwork sites in China. (Produced by R 3.4.3 with packages “maps” and 
“mapdata” (Brownrigg, 2016; Brownrigg et al., 2017; R Core Team, 2017)) 
2.2. Plant material 
Fruits of L. barbarum and L. chinense were collected during fieldwork in China; 
samples were collected directly from the farmers, or offered by the institutions visited, 
or bought in Zhongning Goji Distribution Center, Julu Goji Yinhua Market, Xinjiang 
Jinghe Goji Market, Chengdu Hehuachi Chinese Herbal Medicine Market, and 
An’guo Chinese Herbal Medicine Market. Exported goji samples were bought in 
Switzerland, the UK, Germany, Poland, and Ireland. An authenticated reference 
standard sample of L. barbarum fruit was bought from the National Institute of Food 
and Drug Control of China, batch No. 121072-201410. Moreover, fruits with voucher 
specimens were collected in the National Lycium Germplasm Bank in Ningxia, 
Zhongning County of Ningxia, and Julu County of Hebei in July of 2016. Vouchers 
are deposited in the herbaria of the University of Zürich and ETH Zürich (Z+ZT). All 
samples are listed in Table 1. 
Table 1 Sample information 
Sample Origin Species Stakeholder Quality grade 
Price* 
(Yuan/kg) 
Q1 Qinghai Lycium Independent farmer Rough 40~60 
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barbarum L. 
(LB) 
Q2 Qinghai LB Independent farmer Rough 40~60 
Q3 Qinghai LB Independent farmer Rough 40~60 
Q4 Qinghai LB Independent farmer Rough 40~60 
Q5 Qinghai LB Independent farmer Rough 40~60 
Q6 Qinghai LB Independent farmer Rough 40~60 
Q7 Qinghai LB Independent farmer Rough 40~60 
Q8 Qinghai LB Independent farmer Rough 40~60 
Q9 Qinghai LB Independent farmer Rough 40~60 
G1 Gansu LB Independent farmer Rough 40~60 
G2 Gansu LB Independent farmer Rough 40~60 
G3 Gansu LB Independent farmer Rough 40~60 
G4 Gansu LB Independent farmer Rough 40~60 
M1
Inner 
Mongolia 
LB 
Independent farmer Rough 40~60 
M2
Inner 
Mongolia 
LB 
Independent farmer Rough 40~60 
M3
Inner 
Mongolia 
LB 
Middleman Rough 70 
M4
Inner 
Mongolia 
LB 
Middleman Rough 65 
X1 Xinjiang LB Retailer Conventional 70 
X2 Xinjiang LB Retailer Conventional 80 
X3 Xinjiang LB Retailer Rough 70 
X4 Xinjiang LB Retailer Conventional 70 
X5 Xinjiang LB Retailer Conventional 100 
X6 Xinjiang LB Retailer Conventional 60 
X7 Xinjiang LB Full-VIVC firm Green food 100 
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N1 Ningxia LB Full-VIVC firm Organic 130 
N6 Ningxia LB Full-VIVC firm Conventional 76 
N7 Ningxia LB Full-VIVC firm Conventional 70 
N8 Ningxia LB Full-VIVC firm Conventional 70 
N9 Ningxia LB Independent farmer Rough 60 
N10 Ningxia LB Retailer Conventional 50 
N11 Ningxia LB Independent farmer Rough 60 
N12 Ningxia LB Independent farmer Rough 40~60 
N13 Ningxia LB Retailer Conventional 76 
N14 Ningxia LB Independent farmer Rough 40~60 
N15 Ningxia LB Independent farmer Rough 40~60 
N16 Ningxia LB Independent farmer Rough 40~60 
N17 Ningxia LB Independent farmer Rough 40~60 
N18 Ningxia LB Independent farmer Rough 40~60 
N19 Ningxia LB Full-VIVC firm Organic 130 
N20 Ningxia LB Full-VIVC firm Conventional 70 
N21 Ningxia LB Full-VIVC firm Conventional 80 
N22 Ningxia LB Full-VIVC firm Conventional 70 
E2 Germany LB Retailer Conventional 289 
E3 Switzerland LB Retailer Conventional 632 
E4 Switzerland LB Retailer Organic 590 
E5 Switzerland LB Retailer Green food 489 
E6 Switzerland LB Retailer Conventional 312 
E7 Switzerland LB Retailer Organic 522 
E8 Switzerland LB Retailer Conventional 180 
E9 Switzerland LB Retailer GMP 459 
E10 Switzerland 
LB 
Retailer 
GMP, ISO 
9001 
459 
E12 Switzerland LB Retailer Organic 394 
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E13 UK LB Retailer Conventional 186 
E14 UK LB Retailer Conventional 202 
E15 UK LB Retailer Conventional 174 
E16 UK LB Retailer Conventional 169 
E17 UK LB Retailer Conventional 227 
E18 UK LB Retailer Pharmacy 967 
E19 UK LB Retailer Pharmacy 967 
E20 UK LB Retailer Conventional 162 
E21 UK LB Retailer Organic 531 
E22 UK LB Retailer Pharmacy 677 
E23 Ireland LB Retailer Conventional 260 
E24 Ireland LB Retailer Conventional 288 
E25 Ireland LB Retailer Conventional 206 
E26 Ireland LB Retailer Conventional 231 
E27 Switzerland LB Retailer Conventional 426 
E28 Poland LB Retailer Organic 302 
E29 Switzerland 
LB, declared 
LC 
Retailer Organic - 
E30 Switzerland LB Retailer Conventional - 
E31 Switzerland LB Retailer Organic - 
H1 Hebei LB Independent farmer Rough 25~50 
H2 Hebei 
L. chinense 
Mill. (LC) 
Retailer Conventional 180 
H3 Hebei LC Retailer Conventional 180 
H4 Hebei LC Independent farmer Rough 25~50 
H5 Hebei LC Retailer Conventional 60 
H6 Hebei LC Retailer Conventional 60 
H7 Hebei LC Retailer Conventional 180 
H8 Hebei LC Retailer Conventional 180 
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H9 Hebei LC Retailer Conventional 180 
H10 South Korea LC Retailer Conventional - 
H11 Hebei LB Retailer Conventional 60 
2.3. Pesticides and sulphur residue measurement 
High sensitive pesticide detector cards (Oasis Biochem batch number: 
00120161911, China) were used to measure organophosphorus and carbamate 
pesticides. Added 2 drops of washing solution to a plain fruit surface, and then rubbed 
with another fruit; transferred 1 drop of the solution to the white side of the test card; 
waited for 10 min; and then folded the test card and kept at 38 ℃ for 3 min; and then 
checked whether the card was blue. After measurement the samples were categorized 
in three groups: frequent, seldom, or rare contamination. 
SO2 test tubes (Oasis Biochem, batch number: 20160425, China) were used to 
measure SO2 residue. Soaked 0.5 g dried goji in 10.0 ml water for 10 min, and then 
transferred 1.0 ml of solution into a SO2 test tube and shaked, and 3 min later 
compared the test tube to the colourimetric card. Control check was tested with pure 
water for each batch. Residues were presented as frequent, seldom, and rare according 
to the test results. 
2.4. Value chain analysis 
Firstly, procedures of goji production were compiled into an ordered flow sheet; 
secondly, stakeholders were added to corresponding procedures, so that stakeholders 
in the same chain were linked; thirdly, the labour cost and non-labour cost (mainly 
consists of materials, living costs, and outsourcing costs) of all stakeholders were 
calculated based on the interview data and cross-checked with information from goji 
industry, and then converted into Yuan/kg; fourthly, pesticides residue and sulphur 
residue of goji were linked with stakeholders. Finally, primary production behaviour 
was appended to corresponding stakeholders. The structure of value chains was 
mapped, and the financial performance, production behaviour, and quality of goji was 
analysed for each chain. 
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3. Results and discussion
3.1. Industrial structure and value chains 
The earliest goji cultivation record was found in Qianjin Yifang published around 
C.E. 700 during the Tang Dynasty (Sun, 1998). Since the Ming Dynasty (around 
1’300 C.E.), goji from Ningxia was listed in the tribute to the emperor, indicating that 
Ningxia yielded good quality goji (Cao and Wu, 2015). Since the 1960s, goji was 
introduced to Gansu, Xinjiang, Inner Mongolia, Qinghai, Tibet, and Hubei (Cao and 
Wu, 2015). Although Hebei was an independent historical production area with its 
unique germplasm, the superior cultivar from Ningxia was also introduced; therefore, 
commercial goji of two species were cultivated in Hebei. With a long production 
history, the goji industry formed several mature value chains. Although there have 
been many new products, dried fruits are still the main consumable. 
Typically, goji goes through six stages before it reaches its consumer: 1) Cultivation, 
including activities such as ploughing, planting, pruning, irrigating, fertilizing, pest 
and disease controlling, and harvesting; 2) Preliminary processing, or roughing, 
applied on the fresh fruit, and including surface treatment and preliminary drying of 
fresh fruits (moisture is reduced to ca. 17%), as well as removing impurities; 3) 
Procurement, i.e. trading of rough goji produced in step 2; 4) Processing, including 
re-drying (moisture ≤ 13.0 %), removing impurities by winnowing, commercial 
grading, and packaging; 5) Wholesale, mainly to nonlocal markets; and 6) Retail. In 
each of these steps, different stakeholders can play a role, resulting in various forms 
of value chains (Fig. 3). 
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Fig. 3 Primary goji value chains (VCs) and the stakeholders involved. VCs 1, 2, 
3, 4 are based on independent farmer; VCs 1, 2, 4, 7, 8 end with retailer; VCs 5, 6, 
and 9 are Full-VIVC; VC 10 is for exporting. 
A key difference is found at the beginning of the VCs. 1) VCs 1 - 4 are based on 
independent farmers (with relatively small goji fields) offering their products to 
middlemen or other buyers; 2) VCs 5 is run by individual farmers (with small goji 
fields); 3) VCs 6 - 7 start with farmers involved in agricultural cooperatives (with 
relative large fields); 4) VCs 8 - 10 are charged by the cultivation-processing-trading 
integrated firms (with large-scale goji plantations). Among these four types of VCs, 
VCs 6 - 7 show horizontal cooperation. It is found that products of the same origin 
may flow into different VCs, which promotes the diversification of VCs. 
Products of the ten VCs will finally reach their consumers by four channels, which 
consist of farmers, retailers, shops of full-vertically integrated value chains, and 
external retailers. VCs 1, 2, 4, 7, and 8 end with a retailer and this kind of merging 
increases the complexity of goji VCs. E-commerce is also important in goji trading. 
While E-commerce has been involved in VCs 3, 5, 6, it is increasingly accepted by 
retailers of other VCs as well. 
Additionally, vertical integrations at different levels are found in goji VCs. Some 
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stakeholders (e.g., processing firm) take over the roles of others, inducing vertical 
integrations. For example, VCs 2, 3, 7, 8 are partial-VIVCs, while VCs 5, 6, 9, which 
are controlled by single stakeholders, are full-VIVCs. 
As traditional value chain, VC 1 has played an important role in the domestic goji 
market for decades. Independent farmers grow, harvest, and preliminarily process goji. 
Rough goji is sold via middlemen to processing firms; goji is further processed and 
bulk packaged and sold to retailers, who sell the product to the consumers. VC 1 is 
especially prevalent for goji cultivated outside Ningxia, such as from Gansu, Qinghai, 
and Inner Mongolia. In Qinghai, for example, independent farmers often have large 
goji fields, but the local firms are not sufficient for processing and local consumption 
is limited; therefore, middlemen sell the harvest to processing and trading centres in 
Ningxia. In average middlemen stay in Qinghai for five months every year, and are 
very important for this cross-province chain. 
VC 2 and VC 3 are the results of the business expansion of processing firms. Due 
to the convenience of local trading centres, many processing firms are able to procure 
rough goji directly from the farmers. As the middleman’s participation leads to price 
increase, this upstream expansion strategy results in direct economic benefits for the 
processing firms. Processing firms’ direct procurement is not only found in local 
markets, but also in nearby production areas, for instance, firms in Ningxia may 
procure goji in Gansu. Additionally, the development of E-commerce makes it 
possible for a processing firm to expand downstream. Just like VC 3, the 
processing-trading firm is able to play the roles up to the retailer. 
In VC 4, the brokers act as a bridge between farmers and nonlocal retailers. 
Contracts are made between the brokers and retailers: brokers procure rough goji, but 
outsource the processing, and finally send processed goji to the retailers; retailers will 
pay commission to the broker depending on the amount of goji. 
VC 5 is a one-stop value chain conducted by self-operating individual farmers with 
relative large farms (ca. 1 to 2 hectares), who hire farm workers for production and 
processing. They sell their products via their own online shops. They may also sell 
their products to wholesalers. 
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VC 6 and VC 7 are agricultural cooperative-based value chains. Agricultural 
cooperatives are encouraged by the related governmental departments with beneficial 
policies. Farmers involved will get financial and technical support from the 
cooperatives, such as means of production, facilities for processing, and training in 
production technologies, and their products will be sold collectively, either to 
wholesalers, or consumers by online shops. 
VC 8, VC 9, and VC10 are controlled by firms which control cultivation, 
processing and trading and are based on large-scale farms of over dozens of hectares. 
Their products are mainly sold to nonlocal retailers or consumers by their chain stores 
or online shops. In the case of the export chain VC 10, products are sold to foreign 
wholesalers who distribute to retailers such as supermarkets, groceries, and 
pharmacies. 
3.2. Financial performance of stakeholders 
Value of a product is created by the stakeholders’ production activities. In different 
value chains, stakeholders always play different roles, and contribute different types 
of adding value by their labour inputs and non-labour inputs. Table 2 shows the 
labour cost and non-labour cost along stages of the 10 main value chains. 
Table 2 Labour cost (LC) and non-labour cost (NLC) of stages along goji value chains 
Stage Cultivation and roughing Procurement 
Processing and 
wholesale 
Retail* 
Cost LC NLC LC NLC LC NLC LC NLC 
VC 1 15.2 or 17.7 14.7 or 9.7 0.16 0.47 2.2 2 4.4 or 1.5 2 or 2.1 
VC 2 15.2 or 17.7 14.7 or 9.7 0.16 0.47 2.2 2 4.4 or 1.5 2 or 2.1 
VC 3 15.2 or 17.7 14.7 or 9.7 0.16 0.47 2.2 1.3 1.5 2.1 
VC 4 15.2 or 17.7 14.7 or 9.7 0.65 0.1 0 4.8 4.4 or 1.5 2 or 2.1 
VC 5 15.2 or 17.7 14.7 or 9.7 0 0 0 4.8 1.5 2.1 
VC 6 15.2** 14.7 0 0 2.2 2 4.4 or 1.5 2 or 2.1 
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VC 7 15.2** 14.7 0 0 2.2 2 4.4 or 1.5 2 or 2.1 
VC 8 15.2 or 20.8*** 14.7 or 26.1 0 0 2.8 2.1 4.4 or 1.5 2 or 2.1 
VC 9 15.2 or 20.8*** 14.7 or 26.1 0 0 2.8 1.3 1.5 2.1 
VC 10 20.8*** 26.1 0 0 2.8 4.7 - - 
* For E-commerce, postage is borne by buyer; ** Policy: land rent free for 3 years; *** Policy: financial support
for land rent and drying facility. Costs are presented as Yuan per kg of dried goji.
Most of the adding of value is achieved during the stage of cultivation and roughing. 
Non-labour cost at this stage consists of land cost, irrigation cost, fertilizer, and 
pesticides; labour cost includes work to care for the field, harvesting, and drying, and 
harvesting is the most costly part (ca. 45% of the whole costs), with an average of 
13.5 Yuan (2.1 USD) / kg. However, the reward of people harvesting is not consistent 
with their labour input, and almost all of them are not satisfied with the working 
conditions. They need to pick fresh goji 15 hours per day, even during the hottest 
hours; with such intensive labour input, experienced harvesters can earn ca. 135 Yuan 
(21.3 USD) per day while the average wage is 90 Yuan (14.2 USD). Although 
harvesting machines exist; they are not widely applied though as they reduce labour 
input slightly but cause more impetus. For drying, farmers in VC 1 to 5 have 
alternative methods: i) drying in the sun, which needs more labour input but saves 
costs; ii) or drying in the artificial drying room by outsourcing to agencies, which 
costs less labour but processing charges of 5 Yuan/kg. As a traditional approach, the 
former is often practiced by independent farmers; considering their large amount, the 
latter is suitable for VC 6 to 10. Additionally, large-scale cultivation gains financial 
support from the government: for those with goji fields larger than 1.33 hectares, land 
use is for free during three years; also building of drying rooms can be done with the 
help of partial financial subsidies. For organic production chains, VC 8, 9, and 10, 
costs are higher because of by increased cost of labour and organic fertilizer, and the 
cost for certification and management. Cultivation and roughing add most value to 
goji, but independent farmers obtain small margins only because of the risk of price 
fluctuation and their low bargaining power. 
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Procurement is a key process in VCs 1 to 3 and is driven by middlemen. Their costs 
include procuring and reselling labour, travelling cost, and transportation cost. As a 
linkage of bulk trading among different geographical sites, middlemen need a rather 
high capital turnover, ranging from 0.6 to 1.5 million Yuan. As the turnovers are not 
always smooth, credit operations are important to them. For credits, 
non-governmental organizations such as goji chambers of commerce are founded, 
which provide financial guarantees to their members. However, in other chains, the 
function of middlemen are omitted or replaced, e.g. by brokers in VC 4. Compared to 
the cost of middlemen, those of brokers are higher in labour input and lower in 
non-labour input. This may be due to the smaller amount of goji processed by brokers 
per day (ca. 100~200 kg per day vs. ca. 1000 kg per day by middlemen), which 
increases the average cost of labour; brokers are working locally, which leads to low 
travelling costs. 
Processing and wholesale are also labour-intensive stages, which include 
colour-based separation, re-drying, hand selecting, size-based grading, and 
transportation. The operational cost of the whole is 4.2 Yuan/ kg. In case of the direct 
selling chain (VC 3) the cost on transportation decreases; however, processing charge 
for outsourcing is 4.8 Yuan/ kg, as in VC 4 and VC 5; in the well-controlled chains 
(VC 8, 9, and 10), cost for quality control increase. 
Retail, mainly run by high-street or shopping mall stores or online shops, is the 
final step to reach the consumer. Physical stores are traditional, which can be chained 
or independent, and the additional cost is made up of rent, labour and packaging. Due 
to its low start-up cost and operational cost, online shops become increasingly popular. 
There is no restriction to location, and to set up a new online shop, 10 000 Yuan (1580 
USD) is enough, which is much cheaper compared to a small physical store (at least 
60 000 Yuan (9480 USD)). According to our internet investigation, much more goji is 
sold by taobao.com compared to physical stores. For example, on November 11th, 
2017, during the online shopping festival, about 179 tons of goji were sold in one hour. 
The monthly sales volume of a common physical shop is about 450 kg, which is lower 
than that of an online shop (ca. 4200 kg). Online shops are favoured both by retailers 
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and consumers because of their low costs and shopping convenience. The export 
chain of organic goji, VC 10, has higher cost on quality control, customs clearance 
and international transportation. Outside of China goji is typically sold in health food 
shops, Asian markets and pharmacies, as well as online shops. According to Table 1, 
differences in the retail were found between the conventional goji and quality certified 
goji in domestic market, while the exported goji enjoys a much higher price. 
The stakeholders will obtain profit by margin when they sell their products to the 
next stakeholder and the margin is impacted by the stakeholders’ bargaining power 
and price fluctuation. As is summarized by Coff (1999), bargaining power is 
determined by the stakeholder’s capacity of unified action, access to information, 
replacement cost, and exiting cost. Evaluated by these criteria, the large stakeholders 
have strong bargaining power. In VC 1 for example, independent farmers, especially 
those in rural areas, do not have reliable access to market information; while their 
rival, the middlemen, have direct contacts with the distribution centres; as a result, 
farmers are often disadvantaged. The price fluctuation of rough goji during the last 
five years (Fig. 4) also indicates the drawback of independent farmers. 
Fig. 4 Price fluctuation of rough goji in local markets from 2013 to 2017. The 
average monthly price data were extracted from http://www.zyctd.com/. 
The price of rough goji ranges from 24 Yuan (3.8 USD) / kg to 60 Yuan (9.5 USD) / 
kg, and the coefficient of variation (CV) is between 14.26 % and 26.23%. The lowest 
cost is 27.4 Yuan (4.3 USD) /kg; thus, the price can be lower than the cost, which 
results in a deficit for the farmers. Although our interviewees may storage goji when 
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the price is lower than they can accept, it is still a bet: the quality of goji will decrease 
during (prolonged) storage, and it is not certain that prices will rise soon. As a result, 
independent farmers in Ningxia started to turn goji into maize fields, which provides a 
more stable income. Alternatively, independent farmers are integrated in agricultural 
cooperatives, within which they obtain technological support, sale information, and 
stronger bargaining power. Large-scaled goji production is largely supported by 
governmental funding, such as reduced land rent and allowance for drying facilities. 
These economic conditions promote the larger scale production of goji in the 
upstream value chains, such as VCs 6 to 10. 
The midstream (procurement, processing, and wholesale) which is traditionally 
charged by middlemen, processing firms, and trading firms may be prone to poor 
coordination of stakeholders. This results in the risk of discontinuity of material flow 
and financial return, which are vital for smallholders. For example, an overdue 
payment may lead to bankruptcy of a middleman. Thus, there is a trend towards 
horizontal coordination in the midstream, such as VCs 2 to 10. 
Although procurement price fluctuates drastically, the retail stage enjoys a stable 
price, offering a stable market to the stakeholders who are close to the consumers. 
This may stimulate processing firms and agricultural cooperatives to extend 
downstream to open retail businesses (VCs 3, 6, 9), or may even lead to the rising of 
self-operation farms (VC 5). 
 
3.3. Quality evaluation of goji along value chains 
The quality criteria of goji are published in different types of documents, such as 
pharmacopoeias and industrial standards (esp. of the food industry). Fruit weight and 
sugar contents are commonly used indices, while the contaminants such as pesticides 
residue, sulphur residue and heavy metals are often controlled for safety reasons. 
However, when being asked “what is good quality goji?” our interviewees always 
referred to the morphological and sensory traits of goji but never safety issues. 
Therefore, a quality investigation of goji from different value chains was exerted and 
the results are shown in Table 3. 
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Table 3 Quality evaluation of goji and possibility of hazard risks along different value chains 
Value 
chain 
Traceability Certify Control 
Pesticide 
residue 
Sulphur 
residue 
Possibility of hazard risks  
Cultivation Drying Processing 
VC 1 No No Weak Frequent Frequent Likely Possible Improbable 
VC 2 No No Weak Frequent Frequent Likely Possible Improbable 
VC 3 No No Weak Frequent Frequent Likely Possible Improbable 
VC 4 No No Weak Frequent Frequent Likely Possible Improbable 
VC 5 Yes No Weak Frequent Seldom Possible Improbable Improbable 
VC 6 Yes Maybe Medium Seldom Seldom Possible Improbable Improbable 
VC 7 Yes Maybe Medium Seldom Seldom Possible Improbable Improbable 
VC 8 Yes Yes Strong Rare Rare Improbable Improbable Improbable 
VC 9 Yes Yes Strong Rare Rare Improbable Improbable Improbable 
VC 10 Yes Yes Strong Rare Rare Improbable Improbable Improbable 
 
As an effective quality control tool complied with legislation in food industries, 
traceability was applied to improve the safety of food and the confidence of consumer, 
as well as to connect producers and consumers (Aung and Chang, 2014; Dabbene et 
al., 2014; Regattieri et al., 2007). However, goji of the value chains including 
independent farmers, viz. VC 1 to VC 4, have poor traceability. Since the independent 
farmers sell their goji in large quantities to other stakeholders, traceability becomes 
impossible. In other chains, where rough goji is directly processed, traceability is 
feasible. With the increase of consumers’ concerns on traceability and the 
development of information technology, a traceability system for goji has been 
available to the public by Quick Response (QR) Code since 2015. This QR code has 
also been encouraged by the government, for example, Zhongning County offers an 
allowance of 0.03 Yuan / piece. Since bulk goji loses traceability at the auction, but 
policy and consumers are in favour of it, value chains VC 1 to VC 4 are inferior in 
this respect. 
Certification of a product, such as organic food, increases consumer’s confidence, 
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especially in the health food market. Driven by the market, goji production is subject 
to certification. Perhaps the most attractive certification is the organic certification. 
However, in 2012 considering the complexity of goji production, Chinese 
Certification and Accreditation Administration (CNCA) discontinued organic 
certification of goji in China, and goji products in China were not permitted to be 
advertised as organic any longer. However, in order to meet the demands of foreign 
high quality markets, goji producers applied for certifications from organizations 
abroad, such as EU organic and HACCP (Hazard Analysis Critical Control Point). 
Practically, small stakeholders cannot afford these certifications. On the other hand, 
companies involved in VC 8 to 10, who deal with large amounts of products for high 
quality markets, are always certified. For agricultural cooperatives, certifications are 
always not certified. 
Formal legally binding regulations or self-regulations are considered to be essential 
for good quality (Booker and Heinrich, 2016; Booker et al., 2015). However, without 
a powerful regulatory authority, and weak self-regulation, the processes of the 
individual stakeholders are generally not well-regulated. Conventional production 
relies on chemical pesticides and biocides for pest and disease control, and chemicals 
will be applied 8 to 10 times during an annual production cycle. Independent farmers 
tend to apply excessive amounts of chemicals, which leads to problematic residues. 
Furthermore, a few farmers paid little attention to the safety interval before harvesting. 
These undesirable conditions have been caused by: poor education on how to use 
chemicals properly, and, while recommendations from pesticide sellers exist, no 
powerful regulatory authority controls the use of these substances. Also, pesticide 
residue detection is costly and therefore largely lacking in the value chains VC1 to 
VC4. Compared to pesticides, sulphur is easier to detect and control, but overuse still 
exist in products from some value chains. 
Safety hazards of goji samples are found to be linked to practices in cultivation, 
drying, and processing, and mainly existed in the independent farmers’ value chains. 
During cultivation, goji is exposed to pesticides; when drying, goji may be exposed to 
pesticides again, as well as unhygienic conditions if dries by the road side; and while 
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processing, low quality products may again be exposed to unhygienic conditions. 
 
3.4. Relationship among behaviour, revenue, and quality 
Goji is traditionally consumed as medicine and food. Nowadays, there is an 
increasing demand for high quality goji products. Therefore, goji products are 
involved in two types of markets: the conventional market and the high quality market. 
Since products for these two markets differ completely in their supply chain, their 
behaviour-economic-quality was analysed comparatively (Fig. 5). 
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 Fig. 5 Critical measures and their advantages/disadvantages along value chains of 
conventional market and high quality market (Based on Booker and Heinrich (2016)) 
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Stakeholders in both types of value chains want to increase profit, however, with 
different measures: in conventional market oriented value chains measures are taken 
to decrease costs and increase yield which causes quality loss; while in the high 
quality oriented chain products’ quality and firms’ reputation are improved, which 
increases the overall costs. High quality goji producers would get higher revenues 
from the consumers, while stakeholders of the conventional market will get paid less. 
Therefore, the behaviour and revenue of stakeholders are linked with the quality and 
target market of products (Fig. 6). 
 
Fig. 6 The relationship among the target market, revenue expectation, behaviour, 
and quality 
 
The intended target market has direct impact on stakeholders’ revenue. According 
to our investigation, the price of goji in conventional market (40 ~ 60 Yuan (6.3 ~ 9.5 
USD) /kg) is lower than that of the high quality market (such as green food and 
organic, 70 ~ 130 Yuan (11.0 ~20.5) /kg). The revenue expectation will induce the 
stakeholders’ behaviour. Stakeholders for conventional market are inclined to reduce 
the production cost. Lower production cost results in behaviours which often pose 
quality risks, such as the application of pesticides. Consequently, the quality of goji is 
a direct consequence of the commercial decisions and the resulting production 
practices by the various stakeholders. Also, the quality of goji will further determine 
which market it could go. VCs 1 to 4 are examples of conventional market value 
chains. With the traditional target of getting high yields, chemicals and unhygienic 
measures are applied to goji without professional guidance, therefore, quality 
problems are common and these goji could enter the conventional market with 
relative lower revenue. Products of VCs 5 to 7 can enter both markets, although they 
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may not have quality certifications. Their production behaviours are mainly 
self-regulated, and reputation is built by reliable production and traceability. Value 
chains VC 8 to VC 10 are for high quality markets, with the effective quality control 
during production and reliable quality certifications, these value chains produce goji 
of high quality, which brings high financial return to the stakeholders. 
 
4. General discussion 
In order to fulfil the increasing demand of the global market, the supply system of 
goji has recently undergone great changes, resulting in a diversity of value chains. 
Vertical integration, horizontal collaboration, outsourcing, and E-commerce are found 
to emerge in goji value chains at different levels. 
Vertical integration is induced by the business expansion of stakeholders. VCs 2 
and 3 are the result of vertical integrations of processing firms, by taking over 
procurement (forward integration) and retail (backward integration). Of all the ten 
value chains, VC 1 is without vertical integration, while VCs 2, 3, 4, 7, 8, 10 are 
partially integrated, and VCs 5, 6, 9 are full VIVCs. Vertical integration was reported 
to have many benefits, such as overcoming barriers among stakeholders, increasing 
financial profits, and decreasing price fluctuation (Görg and Kersting, 2014; Hanson, 
2015; Shahidullah and Haque, 2010). These benefits are all found in goji value chains, 
especially in those full VIVCs (VCs 5, 6, 9). The full vertical integration value chain 
was thought to be a competitive approach, within which all the production stages were 
conducted by one stakeholder (Booker et al., 2016; Gereffi et al., 2005; Shahidullah 
and Haque, 2010). In the case of goji, farmers will get access to the market, as well as 
technological and financial support by joining vertically integrated value chains (Liu 
et al., 2015). Additionally, partial vertical integration attributes to a reliable 
traceability of its products. 
Horizontal collaboration is shown as the alignment of stakeholders in charge of the 
same production stage, e.g. the agricultural cooperative. With a higher level of 
communication, trust, and common goals, agricultural cooperatives have higher 
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revenue for the involved stakeholders, and chemicals used are better controlled 
(Martínez-Victoria et al., 2018; Wollni and Zeller, 2007; Zhou et al., 2018). In the 
value chains VC 6 and 7, farmers of agricultural cooperatives enjoy better economic 
status while the quality of goji is better controlled too. Therefore, for individual 
farmers to join agricultural cooperatives could be a strategy for improving the quality 
of goji and stakeholders’ revenues in VCs 1 to 4. Also the chamber of commerce 
founded by the processing and trading firms is an example of horizontal integration. 
Outsourcing is found in several chains such as VC 4 and 5. Expensive facilities, 
such as artificial drying rooms and grading machines, are not available for the 
smallholders, while the proprietors of these facilities are willing to obtain more profits, 
therefore, the outsourcing business raised. Despite its function of resource allocation, 
outsourcing can bring disadvantages including quality problems (Dinu, 2015; Lahiri, 
2016). Due to the existence of smallholders, the outsourcing would continue. 
E-commerce offers a convenient and inexpensive approach for retailers to build 
direct access to consumers. While goji is produced in distinct areas of China, retail of 
goji gets rid of spatial limitations. Since costs for running an online shop are low, they 
increase in number and are vertically integrated by processing firms. 
5. Conclusions
With an insight into value chains of goji, our results indicate that goji’s quality,
stakeholders’ behaviour and revenue are correlated. It is found that stakeholders’ 
behaviour, which is driven by the target market, leads to quality differences, which 
further determine the financial return of stakeholders. Therefore, coordination of 
relationships in value chains could be a strategy for quality control of goji. 
The diverse value chains are induced by vertical integrations and horizontal 
collaborations, while E-commerce promotes the vertical integration. Vertical 
integration and horizontal collaboration are beneficial to both quality of goji and 
revenue for stakeholders; therefore, the related value chains are increasingly 
developed. Since well-developed VIVCs supply products with good traceability, 
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reliable quality, and ensure adequate financial revenues of the stakeholders involved, 
in the future they are likely to become more important. 
Quality control of herbal medicine products relies on quality regulation frameworks 
and quality inspections. Our study shows that quality is impacted by production 
process and financial performance, indicating that a robust value chain is the core of 
quality control. With a value chain analysis including social-economic and quality 
factors, the present work emphasises the importance of the process control in herbal 
medicine products. 
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SUMMARY 
Despite its increasing popularity with the global healthy food market, goji is still some 
mysterious to the public: Where is it from? What benefits does it have? How is it produced? 
How to get goji of high quality? The present thesis employs an interdisciplinary 
ethnobotanical methods to answer these questions. 
Firstly, by a botanical, ethnobotanical and historical review, the the food and medicine 
use of Lycium in the worldwide was revealed. In total, 35 of the 97 species were found to be 
used as food and/or medicine by peoples from different regions. Regarding to the traditional 
uses of Lycium, the used species, plant parts, and usages are found to be differ amongst 
cultures. The earliest medicinal use of Lycium was found in China (since ca. CE 100), and a 
series of time-continous historical herbals recorded the development of knowledge on Lycium. 
Recently, many phytochemical and pharmacological studies, mostly on goji (fruits of L. 
barbarum and L. chinense), explain the linkage between traditional uses and bioactive 
compounds; the diversity of plant usages offers opportunities for the development of new 
food and or medicine products, and it can be inferred that the phytochemical and 
pharmacological studies will be helpful to the development of other species and usages. It is 
found that the quality criteria for goji differ among regions according to a pharmacopoeia 
comparison, which may lead to obstacles in trading as an international consumption. 
Therefore, a relative uniform quality criterion is recommended. Such a transdisciplinary 
approach will serve as a model for studying traditional food or medicine plants. 
Secondly, by a morphological, metabolomic, and antioxidant bioactive analysis, goji of 
different climatic regions in China was compared. Historically goji was recorded to be 
cultivated in monsoon region, and then the semi-arid was considered to yield the good quality 
goji since ca. 700 CE. Recently, Ningxia is thought to be the “daodi region” of goji, and is 
the centre for goji trading and research. However, our results do not justify superiority of a 
specific production area over other areas. Rather, they suggest using goji from different regions 
for different purposes, based on the specific morphological and chemical traits. The 
metabolomic approach combined with morphological analysis and bioactivity evaluation 
allows for capturing these different goji quality clusters, but, at the same time allows detecting 
outliers such as different species. This would not be possible with exclusive chemical analysis. 
Moreover, considering the obvious differences of metabolite profiles and antioxidant activity 
91
between fruits of L. barbarum and L. chinense, we suggest treating them as two separate 
botanical drugs. Future research on the bioactivity of the two species as well as samples from 
different cultivation areas beyond China will provide necessary data for specific and most 
appropriate uses. 
Thirdly, according to a value chain analysis on goji industry in China, ten value chains 
were idenfied, while the relationship amongst stakeholders’ production behaviours, 
stakeholders’ financial performances, and goji’s quality was revealed. It is found that 
stakeholders’ behaviour, which is driven by the target market, lead to the quality differences, 
which further determine the financial return of stakeholders. Therefore, coordination of 
relationships in value chains could be a strategy for quality control of goji. The diverse value 
chains are induced by vertical integrations and horizontal collaborations. Vertical integration 
and horizontal collaboration are beneficial to both quality of goji and revenue of stakeholders, 
therefore, the related value chains are increasingly important. While the well-developed 
VIVCs supply products with good traceability, reliable quality, and ensure adequate financial 
revenues of the stakeholders involved, they are excepted to become more important in the 
future. While quality is impacted by production process and financial performance, a robust 
value chain is the core of quality control. With a value chain analysis including 
social-economic and quality factors, the present work emphasises the importance of the 
process control in herbal medicine products. 
Overall, this thesis present a systematic knowledge of goji covering the traditional and 
current uses, quality assessment, and value chain. In the meanwhile, it offers a template for 
understanding the ethnobotany and quality control of such botanical consumbles which are 
from traditional to global. Hopefully, this interdisciplinary ethnobotinical study framework 
would be a model for studies on those traditional food and medicine plants. 
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S2 Questionnaires to different stakeholders in goji value chains 
S2.1 Questionnaire (A) for farmers used in fieldwork 
Occupation Gender Ethnicity Age Education level Year of working  
      
Goji acreage Mu Yield per Mu Kg 
In a cooperative Y/N Other crops acreage Mu 
Pesticides and 
fertilizer cost 
Yuan/Mu Amount spent on 
land 
Yuan/Mu 
Drying cost Yuan/Mu Pest Control and 
Prevention 
Personal/Unity measures 
Certified grade of 
quality 
Pollution-free/Green/Organical Products Dried/fresh fruits 
Family size  Number of full 
labor 
 
Monthly living cost Yuan People working on 
goji 
 
A1. What makes good quality? What do you think is the most important technology for getting a high yield 
and good quality? 
 
 
A2. About Family members: students? The old? Other people’s job? Total income and cost? 
 
 
A3. Where are the cultivating technologies from? What species do you plant? Where do you get the 
seedlings from? 
 
 
A4. Pesticides and fertilizer application: Types, quantities, frequency, benefit. Do you know safety use of 
them? 
 
 
A5. What is the most efficient method for drying according to your experience? What method do you use? 
 
 
A6. Please describe what goji materials can get a high price? Whom do you sell goji to? If the price is not 
acceptable, what will you do? 
 
 
 
A7. Do you know the price of other goji products? As well as the price of goji in other province? How? 
Can you use (do you have) smart phone or computer to visit the web? 
 
 
A8. Why do you want to start/stop cultivating goji?(For the new/past goji farmer only) 
 
 
A9. Are you satisfied with the present production model and why? What would you like to change to 
improve the situation?  
 
 
96
S2.2 Questionnaire (B) for pickers used in fieldwork 
Occupation Gender Ethnicity Age Education level Year of working 
Other occupations Hometown 
Organized pickers Y/N Salary for picking Yuan/kg 
Workdays Day Daily cost during 
workdays 
Yuan 
Work hours per day Hour Daily harvest volume kg 
Family size Number of full labor 
Monthly living cost Yuan Number of people 
work on goji 
What makes good quality? What do you think is the most important technology for getting a high yield 
and good quality? 
About Family members: students? The old? Other people’s job? Total income and cost? 
Are there any technical essentials for picking? Does picking affect the quality of goji? 
Who decide the price for picking? And what are the impact factors of price? 
What do you think of the working conditions here? 
How do the farmers pay you? Brokerage of organizer? 
Do you care about the price of goji products? How can you get the goji information? 
How many people from your family come here for the picking? Is your family supporting you to work 
here? 
Can you conjecture the income of farmers? 
Why do you want to join in picking goji? 
More to say: 
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S2.3 Questionnaire (c) for middlemen used in fieldwork 
Occupation Gender Ethnicity Age Education level Year of working 
Supply of goji Stock of goji Kg 
Store form Online/Chain/XB Certified grade of 
quality 
Pollution-free/Green/Organical 
Number of product 
type 
Number of staff 
Cost of the shop Salary of staff Yuan/month 
Transportation cost Packing cost 
Monthly turnover Monthly payoff 
Family size Number of full labor 
Monthly living cost Yuan People working on 
goji 
What do you think is the most important technology for getting a high yield and good quality? 
About Family members: students? The old? Other people’s job? Total income and cost? 
Please describe the features of good quality goji? Do the good goji have a high price? 
What do the consumers most care about goji? 
How do you know the price of goji products? As well as the price of goji in other province? Can you use (do 
you have) smart phone or computer to visit the web? 
Do you have any suggestion to improve the quality of goji products? 
What kind of goji store will be the most popular in the future? 
To what extend will your income be affected by the fluctuations in goji price? 
Are you satisfied with the present production model and why? Do you want to change something to improve 
the situation?  
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S2.4 Questionnaire (D) for retailers used in fieldwork 
Occupation Gender Ethnicity Age Education level Year of working 
Supply of goji Stock of goji Kg 
Store form Online/Chain/XB Certified grade of 
quality 
Pollution-free/Green/Organical 
Number of product 
type 
Number of staff 
Cost of the shop Salary of staff Yuan/month 
Transportation cost Packing cost 
Monthly turnover Monthly payoff 
Family size Number of full labor 
Monthly living cost Yuan People working on 
goji 
What do you think is the most important technology for getting a high yield and good quality? 
About Family members: students? The old? Other people’s job? Total income and cost? 
Please describe the features of good quality goji? Do the good goji have a high price? 
What do the consumers most care about goji? 
How do you know the price of goji products? As well as the price of goji in other province? Can you use (do 
you have) smart phone or computer to visit the web? 
Do you have any suggestion to improve the quality of goji products? 
What kind of goji store will be the most popular in the future? 
To what extend will your income be affected by the fluctuations in goji price? 
Are you satisfied with the present production model and why? Do you want to change something to improve 
the situation?  
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S2.5 Questionnaire (E) for companies used in fieldwork 
Firm size and qualification: 
Scope of business: 
cultivation  fresh fruit   dried fruit  deeper-processed products 
What do you do for quality control? 
Species, pesticides, fertilizer, drying, buying… 
Do you have export business? Is it stricter than the domestic trading? Which sides? 
Do you have any plan for new business and why? 
Please evaluate the present production model: 
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S2.6 Questionnaire (F) for village leaders used in fieldwork 
Village size: 
Population Ethnicity 
People engaged in goji Total farmland 
People in cultivation Farmland for goji 
People in processing Cultivation history 
People in marketing Monthly living cost 
per person 
How many kind of production models are there in the village? 
Are there any farmers start/ stop cultivating goji? Why? 
Are there any non-government organizations for goji production? And what can they do for the farmers? 
What do they do for quality control? 
Species, pesticides, fertilizer, drying, buying… 
What makes good quality? What do you think is the most important technology for getting a high yield and 
good quality? 
Please evaluate the present production model. Do you want to change something to improve? 
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S3 Photos of goji legends papercuts published at: http://www.ethnopharmacology.org/index.htm 
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S4 Photos during fieldwork 
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